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The steroid alkaloid cyclopamine has shown much promise as a treatment for cancers in which 
aberrant hedgehog signaling plays a role. The compound, originally discovered due to its 
teratogenic effects in sheep, binds to the hedgehog signaling receptor Smoothend and prevents 
downstream activation. As this pathway is primarily active during embryonic development, 
overactivation later in life can lead to tumor formation and proliferation. Several studies have 
shown that cyclopamine can inhibit and even reverse tumor growth, but limited supply will 
prevent widespread use upon FDA approval of it or any of its semi-synthetic analogs. As high 
value plant medicinal compounds are in demand, producing them at industrially feasible levels 
is not always possible. Many plant natural products are originally produced in low quantities and 
often from species that are not amendable to cultivation. Production of these compounds in a 
heterologous system is ideal, but first the underlying genes that encode biosynthetic enzymes 
must be discovered. Cyclopamine is produced in one of these non-ideal sources, the slow 
growing Veratrum californicum, a species that has not been successfully cultivated. Our goal 
was to discover the underlying genes in the biosynthetic pathway to cyclopamine and express 
them in the emerging heterologous production system Camelina sativa. Herein, the first four 
genes in the biosynthetic steroid alkaloid pathway to verazine, a hypothesized intermediate of 
cyclopamine, have been discovered by correlating gene expression and alkaloid accumulation. 
In addition, the genes have been successfully introduced into C. sativa under the control of seed 
specific promoters for the production of V. californicum secondary metabolites in seed. Future 
work requires discovery of the remaining cyclopamine biosynthetic genes and metabolic fine 
tuning for increased metabolite yield, but the groundwork has been set for future work using C. 
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Chapter 1: History and introduction of cyclopamine 
1.1 History of Veratrum californicum and cyclopamine 
Peculiar birth defects ranging from pronounced lower jaw to full blown cyclopia were reported to 
occur in lambs born in southwestern and south central Idaho from the early 1900-1950’s (Figure 
1). The incidence of congenital anomalies occurred in up to 25% of offspring in some sheep 
herds (Keeler 1978a). Frequencies were not necessarily accurate as some sheep herders failed 
to report incidences due to fear of gaining a negative reputation of owning poor genetic stock. 
Appropriate breeding practices, however, made genetic causes unlikely (Keeler 1978a). In 
addition, reports of these birth defects appeared to correlate with grazing location as opposed to 
specific breeding lines. Ranchers finally contacted the 
Poison Plant Research Laboratory (PPRL) of the United 
States Department of Agriculture in 1954 for help in 
determining the cause behind the instances (Lee et al. 
2014). 
The PPRL, located in Logan, Utah, helped initially rule 
out genetic causes through breeding experiments by 
mating ewes known to have birthed deformed lambs with 
their own rams (Binns et al. 1959).These results 
indicated what was previously expected; the origin of the 
birth defects was likely caused by foraging. Continued 
investigation led researchers to conduct feeding trials based 
upon a plant common to all ranges where the deformities were 
reported. The malefactor was officially determined to be a 
member of the Melanthiaceae/Liliaceae family (debated 
phylogenetic placement), Veratrum californicum (false hellebore, 
corn lily), a native plant frequently found in mountainous regions 
of the Northwestern United States (Figure 2) (Binns et al. 1963, 
Heretsch et al. 2010). A range in birth defects from mild to severe 
was observed upon ingestion of V. californicum by pregnant 
ewes, including holoprosencephaly (lack of division in forebrain), 
single and double globe cyclopia containing only a single optic 
nerve, and a proboscis emerging from the forehead. In addition, 
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the upper palate was often missing in conjunction with a pronounced lower jaw. The most 
severe cases resulted in aborted lambs (Binns et al. 1962, Keeler 1978a). Continued 
investigation indicated that the birth defects correlated with the time of V. californicum ingestion. 
The highest incidence of cyclops lambs occurred when V. californicum was consumed at day 14 
of gestation, the time when the primitive streak develops in sheep (Binns et al. 1965). 
Consumption of V. californicum at subsequent periods of gestation resulted in malformations of 
the trachea, gut, and limbs (Lee et al. 2014). Now that the causative species and knowledge 
concerning the time of insult for V. californicum exposure was revealed, ranchers could 
minimize incidences of abnormal births by directing animal foraging. These practices have 
successfully kept re-occurrences of birth defects due to V. californicum poisoning low (Keeler 
1978b). 
Even after the discovery of V. californicum as the cause of congenital abnormalities and 
implementation of effective grazing management, researchers at the PPRL continued to search 
for the precise teratogenic agent. Previous studies indicating the inhibitory effects that certain 
steroidal alkaloids had on cell division hinted to researchers that this class of metabolites might 
be of interest (Keeler 1978a). Initial investigations were conducted by testing fractions of 
different V. californicum tissue extracts for teratogenicity. The compounds causing the 
abnormalities were shown to be extractable by benzene/ammonia followed by ethanol (Keeler 
and Binns 1966a, Keeler and Binns 1966b). Subsequently, steroidal alkaloids, both the 
glycosides and parent alkamines from V. californicum, were extracted, purified, and tested for 
teratogenicity in sheep. In addition, structurally related compounds were tested. Only three 
steroidal alkaloids, obtained directly from V. californicum, were found to cause the teratogenic 
effect of cyclopia in lambs. These included cyclopamine (1) (the most potent), cycloposine (2) 
(glycoside of cyclopamine), and jervine (3) (Figure 3)(Keeler and Binns 1968). Additional testing 
with other structurally related steroid based compounds including alkaloids, sapogenins, and 
hormones were conducted in order to elucidate the exact structural component that conferred 
teratogenicity. The results were not 100% conclusive, but point to the presence of the furan ring 
and its respective ether bridge (Keeler 1970a). Further analysis of the teratogenicity of the 
related steroidal alkaloid solasodine (4) provided evidence that the nitrogen in the F-ring was 
required, and its projection in the alpha position may be essential. The basic nature of the 
nitrogen is higher in cyclopamine, which may account for its greater teratogenic effects 
compared to solasodine (Keeler et al. 1976). One early hypothesis concerning the teratogenicity 
of cyclopamine included conversion to an active form in the gut of ruminant animals, but non-
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ruminant animals such rabbits, hamsters, rats, and mice were also susceptible to cyclopamine 
poisoning (Binns et al. 1972, Keeler 1970b, Keeler 1975). In addition, direct application of 
cyclopamine to developing embryos also caused teratogenic effects (Bryden and Keeler 1973, 
Bryden et al. 1973).  
 
Structural elucidation of cyclopamine was discovered first in Veratrum grandiflorum by a 
research group in Japan (Masamune et al. 1964). It was unknown at the time that this 
compound was identical to the compound causing cyclopic teratogenicity in lambs in the United 
States. The structure was similar to the known structure jervine, only missing the ketone moiety 
on the C-11 position, and therefore called 11-deoxojervine. The steroid alkaloid in V. 
californicum was later confirmed to be identical to that in V. grandiflorum by the researchers at 
the PPRL (Keeler 1969). Cyclopamine contains six rings (A-F) and possesses a C-nor-D-homo 
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ring structure (Figure 3). The F-ring is a piperidine structure containing a secondary basic 
nitrogen. The D-ring is connected to the tetrahydrofuran E ring by a spiro connection (Heretsch 
et al. 2010). More information on steroid alkaloids and their structures is described below. 
1.2 Diversity of steroid alkaloids 
A few classes of plants and animals synthesize a wide range of structurally diverse and often 
bioactive steroid alkaloids. The plant families containing the majority of steroid alkaloids (in bulk 
and diversity) include Apocynaceae, Buxaceae, Liliaceae, and Solanaceae. Steroid alkaloids 
have also been discovered in a few vertebrate species and marine animals. Marine 
invertebrates including Zoanthid, Cephalodiscus, and Ritterella in addition to the amphibians 
Salamandra (a genus of six salamanders), Bufo (true toads) and Phyllobates (a genus of poison 
dart frogs) also contain steroid alkaloids. Many have been shown to have significant biological 
activity including therapeutic benefits as well as microbial/fungal growth inhibition. The origin of 
most steroid alkaloids derives from the triterpene skeletons cycloartenol, lanosterol, and 
cholesterol, followed by a numerous combination of chemical alterations. Due to the steroid or 
triterpene origin, they are often referred to as steroidal amines as opposed to true alkaloids that 
derive from amino acids (Cordell 1998).  
Members of the Apocynaceae family (including Holarrhena, Paravallaris, Funtumia, Kibatalia, 
and Malouetia) generally produce steroid alkaloids of two basic types, the conanine-type (5) and 
pregnane-type (6) (Figure 4). The pregnane-type is medicinally useful as alkaloids of this class 
may be converted to steroid hormones. Other biological activities from Apocynaceae alkaloids 
include activity against amoebiasis conferred by the conanine-type steroid alkaloid conessine 
and hepatocarcinogenesis conferred by the pregnane-type steroid alkaloid irehdiamine-A 
(Cordell 1998). 
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Several genera of the Buxaceae are known to contain steroid alkaloids including Buxus, 
Sarcococca, and Pachysandra. There are two main skeletal structures found in this family 
(Figure 4) one including a characteristic cyclopropane ring (7) and one that does not (8). 
Structures of these classes often contain methyl groups at one or both C-4 and C-14 positions, 
making them intermediates between cholesterol and lanosterol type steroids. Some genera also 
contain the pregnane-type steroid alkaloids. Extracts of boxwood (Buxus sempervirens) contain 
the steroid alkaloids cyclobuxine-D and buxamine, and have exhibited medicinal effects against 
several ailments including malaria, syphilis, cancer, and tuberculosis (Cordell 1998). 
Genera of the Liliaceae known to contain steroid alkaloids include Veratrum, Fritillaria, Petilium, 
Zygadenus, and Korolkowia. Three general classes of steroid alkaloids are found in the 
Liliaceae including the cerveratrum-type, jerveratrum-type, and the solanidine-type. These 
classes can be further divided into 5 distinct groups, the cevanine-type (9) (cerveratrum-type), 
the veratramine-type (10) (distinct from jerveratrum-type as it lacks the ether bridge of jervine), 
the jervine-type (11), the solanidine-type (12), and the verazine-type (13) (distinct from the 
solanidine-type as it contains only 5 rings) (Figure 4) (Li et al. 2006). Compounds containing the 
ring structure similar to cholesterol (6-6-6-5) are considered steroid alkaloids (the solanidine and 
verazine-types) and compounds containing a C-nor-D-homo ring system (6-6-5-6) are 
considered isosteroid alkaloids (cevanine, veratramine, and jervine types). The designation C-
nor-D-homo refers to the C-ring having one less carbon (‘nor’) and the D-ring having an 
additional carbon (‘homo’). Cyclopamine falls into the jervine-type as it possesses a hexacyclic 
skeletal system with a C-nor-D-homo ring structure in addition to an ether bridge between the D 
and F-rings, forming the tetrohydrofuran E-ring. In addition, a spiro connection is found between 
D and E-ring at the C-17 position. Cevanine-type alkaloids are highly hydroxylated with a 
distinctive C-4, C-9 linkage between the A and B-rings. Alkaloids of the veratramine type are 
missing the ether bridge and therefore lack a 6th ring in conjunction with a characteristic 
aromatic D-ring (Cordell 1998). Plants of these genera have been used in traditional medicines 
to treat ailments including toothache, sore throat, venereal diseases, wounds, epilepsy, and 
cardiac disease. In addition, crushed Veratrum viride rhizome was applied to snakebites and the 
European Veratrum species V. album was known for its emetic properties. Treatment of 
hypertension with the steroid alkaloid protoveratrine is also known (Chandler and McDougal 
2014). 
Five types of steroid alkaloids found in the Solanaceae (including the genera Solanum and 
Lycopersicon) are the solanidine-type (12), spirosolane-type (14), solacongestidine-type (15) 
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solanocapsine-type (16), and jurbidine-type (17) (Figure 4). The solacongestidine-type is 
essentially the same as the verazine-type, but different sources have slightly different 
classifications, so both are relevant terms. Medicinal value from Solanaceae alkaloids is marked 
as they can serve as precursors to steroidal hormones. Antimicrobial activity has also been 
detected from several compounds (Cordell 1998). In addition, α-tomatine, a glycosylated steroid 
alkaloid from Lycopersicon esculentum, has exhibited antineoplastic activity in prostate cancer 
cells (Lee et al. 2011, Lee et al. 2013a, Lee et al. 2013b). 
The distinct types of steroid alkaloids are not necessarily unique to each genus as several 
alkaloids of the same type can be found among the different families. For example, the 
solanidine and verazine-type can be found in the Liliaceae and the Solanaceae. Also, the 
pregnane-type is found in both the Apocynaceae and Buxaceae. However, the cevanine, 
veratramine, and jervine-types that contain the characteristic C-nor-D-homo ring structure are, 
so far, found exclusively in the Liliaceae (Cordell 1998). 
Steroid alkaloids from the animal kingdom can also differ markedly from those found in the plant 
kingdom. For example, the structurally distinct samandarin (18) is a characteristic steroid 
alkaloid from Salamandra species containing an expanded A ring (Figure 4). Also of note, the 
nitrogen atom was found to derive from glutamine, contradictory to the predicted source for 
nitrogen for steroid alkaloids in plants (discussed below). Also quite distinct from the steroid 
alkaloids in plants are those found in marine organisms. These include the novel dimeric steroid 
backbones like that found in cephalostatin (19) (Figure 4) (Cordell 1998). 
1.3 Hedgehog signaling and cyclopamine 
1.3.1 Discovery of hedgehog pathway 
The teratogenic effect of cyclopamine was eventually discovered in the late 1990s. Inhibition of 
Hedgehog (Hh) signaling in developing embryos resulted in the craniofacial birth defects 
observed (Incardona et al. 1998). The Hh pathway was originally discovered in Heidelberg at 
the European Molecular Biology Laboratory in the late 1970s by Nüsslein-Volhard and 
Wieschaus during mutational studies and their effects on embryogenesis in Drosophila 
melanogaster. In D. melanogaster, this signaling pathway is primarily responsible for 
segmentation and development of the body plan. One of the fifty mutants in the screen resulted 
in larva covered in epidermal spikes. This mutant led to the naming, cloning, and identification of 
the first Hh gene.  
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The Hh signaling pathway is highly conserved from flies to mammals as it plays a predominate 
role in embryonic development. It is responsible for many developmental processes in 
mammals including formation of the limbs, nervous system, teeth, lungs, intestine, cartilage, and 
sperm and is heavily involved in bilateral symmetry. Three well conserved homologs to the D. 
melanogaster Hh gene exist in mammals; Sonic Hedgehog (Shh), Desert Hedgehog (Dhh), and 
Indian Hedgehog (Ihh). Each are involved in unique processes, with Shh being the most 
abundant ligand, having the 
broadest expression and influence 
and being the most well studied 
(Heretsch et al. 2010, Lee et al. 
2014). The hedgehog signaling 
pathway is primarily silenced in 
adults, but reactivation can occur for 
regeneration and injury repair. 
Aberrant overactivation can lead to 
uncontrolled cell growth and 
oncogenesis (McMillan and Matsui 
2012). Cyclopamine inhibition of the 
Hh pathway has been shown to 
downregulate overactivation, 
stopping and even reversing 
tumorigenesis caused by abnormal 
signaling (Taipale et al. 2000).  
1.3.2 Canonical hedgehog signaling 
Canonical hedgehog signaling is activated by the presence of the Hh ligands (Shh, Ihh, and Dhh 
in mammals). Initially, the signal sequence is removed from the nascent Hh peptide to yield a 
~45 kD Hh precursor protein. Then, activation of the ligand begins when the protein undergoes 
autocatalytic-cleavage initiated by the C-terminal domain leaving a 20 kD N-terminal domain 
and a 25 kD C-terminal domain. In addition, a cholesterol moiety is added to the C-terminal end 
of the N-terminal fragment. The C-terminal fragment functions solely in processing while the N-
terminal fragment serves as the signaling molecule. The cholesterol modification results in 
association of the Hh signaling peptide with the membrane, allowing the addition of a palmitoyl 
moiety to the N-terminal end by Skinny Hedgehog (Ski), an acetyl transferase protein. The final 
result is an active signaling molecule (Porter et al. 1996, Varjosalo and Taipale 2007). In the 
Augustin, Megan, 2015, UMSL, p.14 
 
 
absence of active Hh, the 12-transmembrane receptor Patched (PTCH) represses the Hh 
pathway by preventing the 7-transmembrane G-protein coupled receptor-like Smoothened 
(SMO) from entering the primary cilium, a specialized cellular projection involved in signaling. 
Upon activation by Hh signaling proteins, PTCH leaves the primary cilium and is degraded by 
endosomes, resulting in an accumulation of SMO in the primary cilium and activation of the 
pathway (Corbit et al. 2005, Peluso et al. 2014, Rohatgi and Scott 2007). Ligand binding to one 
of the co-receptors of PTCH (CDO, BOC, or GAS1) is also required for activation (Izzi et al. 
2011). Once SMO is active, it prevents the proteolytic processing of Gli2/3 (zinc finger 
transcription factors) to their repressor forms by inhibiting the negative regulator Suppresser of 
Fused (SUFU), Casein Kinase 1(CK1) Protein Kinase A (PKA), and Glycogen Synthase Kinase 
3β (GSK3β) (Cochrane et al. 2015, Hui and Angers 2011). In the absence of signal, Gli2/3 are 
processed into truncated forms that serve as repressors of the hedgehog target genes. 
Therefore, active forms of Gli2/3 induce expression of hedgehog response genes. In addition, a 
positive feedback loop is initiated as active Gli2/3 induce expression of Gli1, a protein involved 
in amplification of the signal. PTCH expression is also induced by hedgehog pathway activation, 
serving to downregulate the signal, thereby playing an opposing role to Gli1 (Figure 5) (Hui and 
Angers 2011, McMillan and Matsui 2012, Niewiadomski et al. 2014).  
1.3.3 Mechanism of hedgehog inhibition by cyclopamine 
The exact mechanism of Hh signaling inhibition by cyclopamine was discovered by the research 
group of Philip Beachy at the Johns Hopkins University School of Medicine with the help of 
collaborators at the Howard Hughes Medical Institute. Beachy’s group was studying hedgehog 
signaling in mammals and generated a cyclops mouse upon mutation of the Shh gene. The 
connection was then made between the outbreaks of cyclops lambs in the 1950’s and Hh 
signaling. Searching for an efficient way to control Hh signaling, his group turned to 
cyclopamine, the causative agent of the teratogenic effects leading to cyclopia (Heretsch et al. 
2010, Keeler and Binns 1968). Beachy’s group first hypothesized that cyclopamine inhibited 
cholesterol biosynthesis, but it was shown that signal transduction was perturbed and the 
synthesis of cholesterol was not involved (Cooper et al. 1998, Incardona et al. 1998). In the end, 
their research showed that hedgehog signaling was inhibited when cyclopamine bound directly 
to SMO and prevented downstream signaling, regardless of Hh ligands(Chen et al. 2002). More 
recent work has shown that native oxysterols bind to the extracellular domain of SMO and are 
required for its ability to send downstream signals. This binding site is distinct from that bound 
by cyclopamine, however, as cyclopamine binds to the heptahelical bundle, a transmembrane 
region of SMO (Nachtergaele et al. 2012, Nedelcu et al. 2013, Sharpe et al. 2015). 
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1.3.4 Abnormal hedgehog signaling and cancer 
Indication of the relationship between the development of cancer and abnormal signaling of the 
Hh pathway originated in patients with the autosomal dominant Gorlin syndrome (Basal-cell 
nevus syndrome). Patients suffering from Gorlin syndrome have skeletal abnormalities, basal 
cell carcinomas, cysts, and cleft lip/palate in addition to other neoplasms and birth defects 
(Gorlin 1995). It was discovered that this syndrome could be attributed to germline mutations in 
PTCH, and therefore abnormal Hh signaling (Hahn et al. 1996, Johnson et al. 1996). Mutations 
in PTCH have also been identified in up to 90% of sporadic basal cell carcinomas (Epstein 
2008). In addition to Gorlin syndrome and basal cell carcinomas, development of 
medulloblastoma has also been associated with reduced function of PTCH (Corcoran and Scott 
2001, Wechsler-Reya and Scott 2001).  
Aberrant Hh signaling has been subsequently shown to be involved in the development and 
progression of numerous cancers through several mechanisms. One mechanism is through 
ligand-independent constitutive activation. In this mechanism, overactivation of the Hh pathway 
occurs regardless of Hh signaling protein. Mutations in PTCH (e.g. Gorlin syndrome and 
medulloblastoma), SMO, or SUFU can fall into this category. Other mechanisms include 
autocrine ligand-dependent (cells respond to over production of its own Hh signal) and 
paracrine ligand-dependent (cells respond to overproduction of Hh signals from nearby cells). 
More evidence supports the involvement of paracrine signaling in cancer growth, highlighting 
the importance of the nearby stromal cells (connective tissue) and the surrounding 
microenvironment. Some research, however, has shown the possibility of autocrine signaling 
playing a role in acute lymphocytic leukemia (Lin and Matsui 2012, Lin et al. 2010, Yauch et al. 
2008).  
Ligand-dependent overactivation of the Hh pathway has been found to play a role in more 
cancer types than ligand-independent overactivation. Production of Hh paracrine factors from 
stromal cells was discovered to assist in the survival of B-cell malignancies, demonstrating the 
importance of the microenvironment in tumor production (Dierks et al. 2007). Overexpression of 
Shh was observed in 70% of pancreata samples from patients with pancreatic carcinoma 
indicating a loss of Hh regulation. This misregulation was not attributed to mutations in PTCH, 
SMO, or SUFU and is therefore ligand-dependent. Expression of PTCH, not detected in normal 
pancreata cells, was also seen in abnormal epithelium and the surrounding mesenchymal cells 
(Thayer et al. 2003). Ligand-dependent overactivation of Hh pathway was also observed in 
some digestive tract cancers, small cell lung cancers, myeloid leukemia, multiple myeloma, 
Augustin, Megan, 2015, UMSL, p.16 
 
 
colon cancer, melanomas, and prostate cancers (Berman et al. 2003, Karhadkar et al. 2004, 
Peacock et al. 2007, Stecca et al. 2007, Varnat et al. 2009, Watkins et al. 2003, Zhao et al. 
2009). Aberrant Hedgehog signaling was also observed in malignant pleural mesothelioma (Shi 
et al. 2012). 
Abnormal Hedgehog signaling is also involved in the proliferation and maintenance of cancer 
stem cells. Using multiple myeloma as a model, researchers discovered the requirement of Hh 
signaling in proliferation of tumor stem cells. The presence of Hh was also necessary to keep 
the stem cells in an undifferentiated state (Peacock et al. 2007). The role of Hh signaling has 
also been established in colon cancer stem cells and myeloid leukemia stem cells (Batsaikhan 
et al. 2014, Varnat et al. 2009, Zhao et al. 2009). Cancer stem cells are attributed to the 
reoccurrence of many cancers and are a particularly important target of cancer treatment. 
1.3.5 Hedgehog signaling inhibition as cancer treatment 
Inhibition of hedgehog signaling in many cancers where abnormal regulation is implicated has 
shown great promise. Treatment of medulloblastoma cell cultures with cyclopamine showed 
specific inhibition and reduction of tumor cell lines by up to 80% while fibroblast cells were 
unaffected (Berman et al. 2002). In another study, cell death and decreased tumor size was 
observed in a medulloblastoma mouse model by preventing hedgehog signaling (Romer et al. 
2004). In prostate cancer, overexpression of PTCH was observed up to 400-fold the normal 
levels in cancer cells as compared to benign epithelial cells. Treatment with cyclopamine 
reversed these effects and inhibited growth in three out of four cell lines tested. In the same 
study, cyclopamine treatment of prostate tumors in mouse models showed suppression and 
regression. Discovery that Hh pathway activation is required in prostate cancer stem cells in 
conjunction with the observed tumor regression indicates the cancer stem cells were also 
effectively treated with cyclopamine (Karhadkar et al. 2004). Increased expression of Hh 
pathway target genes was also observed in colon cancer cells, with a marked increase in 
metastatic tumors. Treatment of colon cancer with cyclopamine inhibited hedgehog signaling, 
caused reduced cell proliferation, increase apoptosis, and even eliminated tumors in mouse 
models for up to one year when treated for 20 days. Treatment of melanoma cultures with 
cyclopamine for 20 days also caused cancer cell death and prevented tumor recovery. Shorter 
treatment periods in the colon cancer study initially eliminated tumors but regrowth was 
observed, highlighting the necessity of Hh signaling for tumor reoccurrence (Stecca et al. 2007, 
Varnat et al. 2009). A reduction in the expression of stem cell specific genes was also seen 
when colon cancer cell cultures were treated with cyclopamine, indicating a possible role in 
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treatment for colon cancer stem cells (Batsaikhan et al. 2014). As for pancreatic cancer, 
cyclopamine treatment was found effective in 50% of cancer cell lines tested. Cyclopamine 
induced apoptosis, reduced cell density, and tumor mass was reduced up to 60% in a mouse 
model (Thayer et al. 2003). Treatment of mouse models with myeloid leukemia showed a 14-
fold reduction in cancer stem cells. In addition, 60% of cyclopamine-treated mice were alive 
after 7 weeks while the control mice did not survive over 4 weeks. It was also noted that earlier 
treatment with cyclopamine was more effective (Zhao et al. 2009) In research with multiple 
myeloma, treatment with cyclopamine inhibited overactivation of Hh pathway and diminished 
clonal capacity of cancer stem cells (Peacock et al. 2007). Another study showed complete 
abolition of lymphoma cancer cells grown on a layer of non-cancerous stromal cells within 48 
hours while the stromal cells were unaffected (Dierks et al. 2007). Targeted inhibition of the Hh 
pathway in cancer cells vs. normal cells by cyclopamine and the marked effects on cancer stem 
cells shows positive attributes for future cancer treatment.  
Further elaboration on the importance of the microenvironment in tumor growth and its potential 
as a therapeutic target was highlighted in two contradictory studies involving the effects of 
cyclopamine / IPI-926 and pancreatic cancer. In one study, the treatment of pancreatic tumors 
with cyclopamine showed a significant reduction of 42% in microvascular density. Angiogenesis 
(growth of new blood vessels) was inhibited and the remaining tumor vasculature was narrow 
and fragmented (Nakamura et al. 2010). A study published one year earlier, however, found that 
treatment with the cyclopamine analog IPI-926 increased the vascular density and increased the 
delivery of the chemotherapeutic agent gemcitabine (Olive et al. 2009). This could possibly be 
due to the difference between cyclopamine and its analog, but the actual effects on cyclopamine 
and growth of vasculature are still debated. 
Several structural variations of cyclopamine have been designed for better solubility and stability 
in order to increase its effectiveness as a cancer treatment. The double bond between C-12 and 
C-13 creates an allylic oxygen in the furan ring, thus acid treatment (as would be encountered in 
the stomach) will cause a break in the ether bridge, followed by aromatization of the D ring 
resulting in toxic veratramine. KAAD-cyclopamine (20) (Figure 6), an analog with an attachment 
to the nitrogen, was shown to have 10-20 times the potency of cyclopamine (Taipale et al. 
2000). Carbohydrate derivatives of cyclopamine prepared with glycosyl azides in a manner 
called “Click Chemistry” (easy chemical modifications under mild conditions) was utilized in an 
attempt to increase solubility. Only one compound of the several tested came close to the 
activity of cyclopamine (Zhang et al. 2008). In attempts to diminish the potential toxic side 
Augustin, Megan, 2015, UMSL, p.18 
 
 
effects of cyclopamine on non-cancer cells, 
some groups have developed cyclopamine 
prodrugs. In one study, cyclopamine was 
conjugated to a protein cleavable by 
prostate-specific antigen (PSA), a serine 
protease that is highly expressed in 
prostate cells; cyclopamine is only 
activated in these cells. A 7-fold 
enhancement of the cyclopamine derivative 
was detected in the presence of PSA as 
opposed to controls without PSA (Kumar et 
al. 2008). Another group designed a 
cyclopamine analog bearing a glycosylated 
poly(ethylene glycol) side chain that is 
cleaved by β-glucuronidase, an enzyme 
known to be highly concentrated in necrotic 
areas of many tumors (Renoux et al. 
2011). None of these analogs have, so far, 
progressed passed the research laboratory. 
Another promising cyclopamine derivative is IPI-926 (21) (Figure 6), advanced by Infinity 
Pharmaceuticals from a batch of semi-synthetic derivatives including the seven-membered-ring 
containing analog IPI-269609. This molecule showed increased solubility and stability with 
positive results in lab settings. Complete regression of a medulloblastoma model was observed 
in tumor bearing mice treated orally IPI-926 as opposed to cyclopamine treatments which 
showed little effect under these conditions (Tremblay et al. 2009). Initial clinical trials also 
showed positive results for patients with basal cell carcinomas (Jimeno et al. 2013). Less 
promising results were obtained, however, in Phase 1b/II clinical trials for IPI-926 treatment of 
pancreatic cancer in conjunction with Gemcitabine and Phase II clinical trials with myelofibrosis. 
Both studies were terminated early as patients either had a lower median survival rate than the 
controls or showed no improvement (Lee et al. 2014). Another Phase I clinical trial is currently 
recruiting participants for IPI-926 in conjunction the chemotherapeutic drug FOLFIRINOX (Ko 
2015). Despite setbacks, overall results for the hedgehog inhibitor cyclopamine and its analogs 
are positive. Due to the complex nature of cancer metastasis, more clinical trials are required 
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before abandoning this potential treatment. All of these cyclopamine derivatives, however, 
require cyclopamine as starting material, so the need for cyclopamine supply is still great. 
Recently, another structurally unrelated Hh antagonist, GDC-0449 (Vismodegib), was approved 
by the FDA for use in adults with basal cell carcinoma. This is the first drug approved for cancer 
treatment by perturbation of the Hh pathway. Mutations in cancer cells are common, and 
multiple treatment options are required. Other cyclopamine analogs and unrelated Hh inhibitors 
have been in development (Ma et al. 2013). The FDA approval of GDC-0449, the continued 
synthesis of more stable, active, and biologically available Hh inhibitors, and the ongoing testing 
of IPI-926 supports cancer therapy by Hh signaling inhibition and highlights the need for more 
research in this field. 
1.4 Cyclopamine supply 
The promising activity of cyclopamine and its derivatives for cancer treatment is complicated by 
the limited supply. The natural source, V. californicum, is a slow growing plant for which reliable 
and robust propagation techniques are yet to be established (Song et al. 2014). Improved 
extraction techniques have been developed, but issues include substantial benzene 
consumption in addition to the limited supply of material. Total synthesis is difficult and 
inefficient, with the most promising technique yielding only 1% cyclopamine. If cyclopamine or 
any of its derivatives are approved for medicinal use, the current supply will not meet the 
demand (Heretsch et al. 2010). Understanding how V. californicum produces cyclopamine is 
one way to propel industrial production. Once the genes producing enzymes that are involved in 
the chemical transformations of cyclopamine are discovered, they can be introduced into 
another, more suitable, organism for production.  
1.5 Current knowledge of steroid alkaloid biosynthesis 
Little is known about the biosynthesis of steroid alkaloids, especially at the gene level. Early 
studies performed in Japan during the 1970’s lead by Kaneko et al. provided a framework for 
steroid alkaloid biosynthesis (including cyclopamine) in V. grandiflorum, but no genes were 
identified (Figure 7). Possible intermediates for cyclopamine, including 22, 26-
dihydroxycholesterol (dormantinol), 22-keto-26-hydroxycholesterol (dormantinone), verazine, 
and solanidine, were established based upon structure and their presence in the plant (Kaneko 
et al. 1978, Kaneko et al. 1979, Kaneko et al. 1970a, Kaneko et al. 1970b, Kaneko et al. 1975, 
Kaneko et al. 1977). Acetate and cholesterol were also established as early precursors by 
feeding their 14C labeled counterparts to V. grandiflorum and monitoring incorporation into 
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steroid alkaloids (Kaneko et al. 1970b). In addition, L-arginine was identified as the source of 
nitrogen in the piperidine ring. The accumulation of L-arginine in the rhizome followed by a 
significant decrease over time correlated with the accumulation of verazine(Kaneko et al. 1976). 
Mechanistically, the closing of the E-ring is hypothesized to occur when the lone pair of 
electrons on the nitrogen of teinemine undergoes a nucleophilic attack on the C-16 in the 
presence of a suitable leaving group. Another experiment revealed the conversion between the 
solanidine and jerveratrum alkaloids may require light. Etiolated V. grandiflorum plants 
accumulated radioactive solanidyl glycoside when grown in the dark. When illuminated, they 
started to accumulate radioactive jerveratrum alkaloids. In addition, this information supports a 
Wagner-Meerwein rearrangement, which would require ATP (Heretsch et al. 2010, Kaneko et 
al. 1979, Kaneko et al. 1972). Interestingly, one study based on the biosynthesis of solasodine 
in Solanum laciniatum indicates the addition of nitrogen directly follows hydroxylation at the C-
26 position, then possibly functionalization at positon 22 (Tschesche and Brennecke 1980). This 
contradiction, however, could be attributed to different pathways in the two species. 





More recently, work on the biosynthesis of α-tomatine, a spirosolane steroid alkaloid from S. 
lycopersicum, has provided some insight on steroid alkaloid biosynthesis at the gene level. 
Researchers used RNAi to downregulate potential biosynthetic genes (based on expression 
correlation studies) and confirmed their functionality by analyzing accumulation of intermediates. 
They found that hydroxylation of cholesterol at position C-22 was followed by hydroxylation at 
position C-26 and that these reactions involved cytochrome P450 (CYP450) enzymes. Several 
steps followed to form the E-ring which involves, at least, a CYP450 and a 2-oxoglutarate-
dependent dioxygenase. Oxidation at position C-26 was also catalyzed by a CYP450 followed 
by addition of an amino group by a transaminase. Members of Solanaceae do not produce 
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jerveratrum alkaloids containing the C-nor-D-homo ring system, however, the study does 
provide information on enzyme classes involved and potential order of transformations. 
1.6 Hypothesis and proposal 
The issue remains that all genes involved in the biosynthesis of cyclopamine are unknown. 
Knowledge of the underlying genes is essential for bioengineering the pathway into another, 
more suitable, biological production system. Our goal is to discover the genes in the 
biosynthetic pathway to cyclopamine and engineer the pathway into the emerging oilseed crop 
Camelina sativa, chosen for its robust growth, low input requirements, and ease of 
transformation (Bansal and Durrett 2015). We hypothesize that correlating a cyclopamine 
accumulation model (based upon the concentration of cyclopamine in different V. californicum 
tissues) with gene expression (obtained by Illumina high-throughput sequencing); we can 
reduce the number of candidate genes to an acceptable level for functional characterization. 
Candidate genes will be selected based upon correlation with the cyclopamine accumulation 
model in conjunction with predicted functional annotation. Genes will be expressed in an Sf9 
insect cell culture system to produce enzymes for testing. Functional enzymes will then be 
transformed into C. sativa and driven by seed specific promoters in order to accumulate V. 
californicum metabolites in seed. This will be the first attempt to discover cyclopamine 
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Steroid alkaloids have been shown to elicit a wide range of pharmacological effects that include 
anticancer and antifungal activities. Understanding the biosynthesis of these molecules is 
essential to bioengineering for sustainable production. Herein, we investigate the biosynthetic 
pathway to cyclopamine, a steroid alkaloid that shows promising antineoplastic activities. Supply 
of cyclopamine is limited, as the current source is solely derived from wild collection of the plant 
Veratrum californicum. To elucidate the early stages of the pathway to cyclopamine, we 
interrogated a V. californicum RNA-seq dataset using the cyclopamine accumulation profile as a 
predefined model for gene expression with the pattern-matching algorithm Haystack. 
Refactoring candidate genes in Sf9 insect cells led to discovery of four enzymes that catalyze 
the first six steps in steroid alkaloid biosynthesis to produce verazine, a predicted precursor to 
cyclopamine. Three of the enzymes are cytochromes P450 while the fourth is a γ-aminobutyrate 
transaminase; together they produce verazine from cholesterol.  
2.2 Significance statement  
The first four enzymes involved in the biosynthesis of the steroid alkaloid verazine, a predicted 
precursor to the antineoplastic cyclopamine in Veratrum californicum, were discovered: 
cholesterol 22-hydroxylase, 22-hydroxycholesterol 26-hydroxylase/oxidase, 22-
hydroxycholesterol-26-al transaminase, and 22-hydroxy-26-aminocholesterol 22-oxidase. The 
pathway to verazine has been refactored in Spodoptera frugiperda Sf9 cells. 
2.3 Author contributions 
D.A.M. collected V. californicum plant material. M.M.A isolated V. californicum RNA. D.R.R. 
analyzed transcriptome data and produced the candidate gene list. D.R.R., A.K.S, and M.M.A. 
cloned candidates into baculovirus expression vectors and expressed them in Sf9 cells. J.M.A. 
and M.M.A. developed and performed enzyme assays to determine enzymatic activity and 
purified metabolites for structure elucidation. C.M.S. and M.O.J. purified metabolites and 
determined structures by NMR. B.S.E analyzed metabolites by LTQ-Velos Pro Orbitrap. M.R.M. 
performed deep phylogenetic analysis of cytochromes P450. J.C.P., P.P.E., M.D.B., A.S., 
G.K.W., and M.K.D. contributed plant materials and RNAseq data from the 1KP project. M.M.A. 
and T.M.K. analyzed data and wrote the manuscript, which was reviewed by all authors. T.M.K. 
directed the study.  
More specifically, I (M.M.A.) cloned contigs 13284 and 12709 and all of their respective 
homologs, and homologs of 2646 (originally cloned by D.R.R.). I also cloned additional genes 
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as indicated in Table S3 and verified the sequences of all genes by DNA sequencing. I 
performed homologous recombination of genes 13284 (and the respective homologs), two 
homologs of 12084, and one homolog of 2646 with baculovirus viral DNA in addition to those 
indicated in Table S3. I performed all Sf9 cell maintenance and infection for enzyme production. 
I conducted all enzyme assays and Sf9 extracts, ran all instruments and analyzed all data for 
enzyme function and product production. I produced the data for and assembled the images for 
figures 1,2,4,5 and supplemental figures S1-S8, S10-S15, and S17. I produced or assembled 
information for tables S5-S7, and S11-S13. I wrote and edited this manuscript with the help of 
Toni M. Kutchan. 
2.4 Introduction 
Plants synthesize numerous specialized metabolites that are used in medicines today (Mishra 
and Tiwari 2011). Their endogenous function is thought to play a role in communication of the 
plant with its environment, as these compounds possess an array of biological activities 
(Mithofer and Boland 2012, Mizutani 2012). An understanding of how these molecules are 
formed serves a dual role: enabling study of the in planta function, as well as development of 
synthetic biology production platforms for source plants that are not amenable to cultivation or 
genetic manipulation.  
In seeking medicines from natural sources, plants synthesizing the nitrogen containing alkaloids 
have proven to be a vital source. Of particular pharmaceutical interest are the steroid alkaloids. 
Members of the families Liliaceae, Apocynaceae, Buxaceae, and Solanaceae are a rich source 
of these alkaloids. The structural similarity of steroid alkaloids to mammalian steroid hormones 
may be responsible for their therapeutic effects (Cordell 1998, Jiang et al. 2005, Zhou 2003). 
Our study focuses on the steroid alkaloid cyclopamine from the Liliaceae family. Members of 
Liliaceae contain three sub-classes of steroidal alkaloids: the jerveratrum-type, the cerveratrum-
type, and the solanidine-type (Cordell 1998). Cyclopamine, also known as 11-deoxojervine, is a 
jerveratrum-type alkaloid that exhibits potent pharmacological properties.  
Cyclopamine was originally discovered due to its teratogenic effect that resulted in craniofacial 
anomalies (cyclopia) in lambs born at high elevation in the northwestern United States in the 
middle of the 20th century (Keeler 1970a, Keeler 1970b, Keeler and Binns 1966b). Studies 
supported by the United States Department of Agriculture found that the California corn lily 
Veratrum californicum was the source of the teratogen in the natural diet of the pregnant ewes 
(Keeler 1968, Keeler 1969, Keeler 1970a). Cyclopamine was discovered to inhibit the 
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Hedgehog signaling pathway by direct binding to the G protein-coupled receptor Smoothened 
(Chen et al. 2002). As such, cyclopamine has shown promising antineoplastic activities against 
several cancers in which Hedgehog signaling malfunction is implicated, including pancreatic 
cancer, renal cell carcinoma, medulloblastoma, basal cell carcinoma, and leukemia (Bahra et al. 
2012, Behnsawy et al. 2013, Berman et al. 2002, Gailani et al. 1996, Lin et al. 2010, Olive et al. 
2009, Taipale et al. 2000). A semi-synthetic analog of cyclopamine, IPI-926, has been in clinical 
trials for treatment of several cancers including pancreatic cancer and leukemia (Lin et al. 2010, 
Olive et al. 2009, Tremblay et al. 2009). Due to complicated total synthesis, wild-collected V. 
californicum is the current commercial source of cyclopamine. Commercial cultivation of the 
plant has not yet been successful. Cyclopamine is thereby an attractive target for 
biotechnological production. The first obstacle to this approach is, however, obtaining 
knowledge of the underlying biosynthetic genes. 
Cyclopamine biosynthesis is believed to begin with cholesterol, a common precursor to most 
steroidal alkaloids (Cordell 1998, Kaneko et al. 1970b). Early studies on species of the Liliaceae 
and Solanaceae families have proposed transformation of cholesterol to metabolites identified in 
plant extracts that include dormantinol, dormantinone, verazine, and etioline. All of these 
molecules are proposed intermediates in the biosynthesis of cyclopamine (Chandler and 
McDougal 2014, Kaneko et al. 1977). Previous feeding studies shed limited light on pathway 
order and suggested that L-arginine is the origin of the nitrogen atom (Kaneko et al. 1977, 
Kaneko et al. 1976, Tschesche and Brennecke 1980). A more recent report on the biosynthesis 
of Solanaceous alkaloids utilizing gene co-expression analysis and RNAi knock-out transgenic 
plants in Solanum tuberosum and Solanum lycopersicum outlines a biosynthetic pathway 
leading to the synthesis of the spirosolane-type steroid alkaloid α-tomatine. The enzyme classes 
identified in the Solanum pathway include several cytochrome P450 enzymes, a transaminase, 
and a 2-oxoglutarate-dependent dioxygenase (Itkin et al. 2013). Questions remain, however, 
concerning the formation of steroid alkaloids in Veratrum as no genes or enzymes have been 
reported. 
Biochemical pathway elucidation in non-model systems has historically taken decades to 
complete, but bioinformatic technologies are revolutionizing the approach. A prominent example 
of former methods used in pathway discovery is morphine biosynthesis in opium poppy, 
Papaver somniferum. Though morphine was discovered in the early 1800’s, the biosynthetic 
pathway is still incomplete at the gene level. Genes encoding only 6 of the 8 enzymes 
committed to the biosynthesis of morphine have been isolated and characterized from the 
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1990’s to the present – several decades of work to uncover fewer than 8 genes (Gesell et al. 
2009, Grothe et al. 2001, Hagel and Facchini 2010, Unterlinner et al. 1999, Ziegler et al. 2006). 
Now, high-throughput sequencing technology enables new approaches to biochemical pathway 
discovery in the non-model system by providing nucleotide sequence data acquisition at a 
previously unparalleled rate. A combination of bioinformatics and high-throughput sequencing 
has the potential to shorten natural product pathway discovery if the challenges of interrogating 
such large datasets from non-model systems is overcome. We present herein the discovery of 
four V. californicum enzymes that catalyze the first six steps from cholesterol to verazine, a 
predicted precursor to the steroid alkaloid cyclopamine. We utilize a biosynthetic gene discovery 
method founded on correlating metabolite accumulation with RNA-seq generated gene 
expression data. By stepwise refactoring of the pathway in Spodoptera frugiperda Sf9 cells, we 
eliminate the need to synthesize biosynthetic intermediates for validation of pathway enzyme 
activity.  
2.5 Results  
2.5.1 RNA-seq and de novo transcriptome assembly 
Multiplex paired-end sequencing of V. californicum cDNA produced from bulb, flower, leaf, fall 
rhizome, spring rhizome, fall root, green shoot, white shoot, and tissue culture samples on two 2 
x 50 bp Hi-Seq channels produced over 201 million raw reads which were analyzed and filtered 
for artifacts/contaminants. The de novo short read assembly generated 56,994 contigs with a 
median length of 323 bp and an N50 of 1,471 bp (refer to Table S1 and Table S2 for Illumina 
reads generated per file and transcriptome statistics, respectively). Information on accessing the 
raw reads and assembled transcriptome can be found in Data S1. Raw mapped read-counts 
were utilized as a metric of relative gene expression. The average contig sequence length 
indicates high quality assembly and was sufficient for downstream sequence alignment and 
phylogenetic gene tree estimation. 
2.5.2 Transcriptome dataset interrogation 
To provide annotation, predicted peptide sequences were queried against the Pfam and 
Superfamily databases in addition to BLAST searches at NCBI using the non-redundant protein 
sequence database. Expression data for each contig was normalized using total reads per 
organ type to serve as the dataset for Haystack (http://haystack.mocklerlab.org/ )(Mockler et al. 
2007).  
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LC-MS/MS determination of the steroid alkaloid profile in the same V. californicum tissues used 
for RNA-seq identified a pronounced accumulation of cyclopamine in rhizome, followed by root 
and bulb (Figure S1), suggesting that biosynthesis occurs in underground organs of the plant. 
Since secondary metabolites are most often synthesized at or near their site of accumulation 
(Huang and Kutchan 2000, Nims et al. 2006, Onrubia et al. 2011, Weid et al. 2004), we initially 
hypothesized that underground tissues (rhizome, root, and bulb) in Veratrum are biosynthetic for 
cyclopamine.  
Since ca. 20 times more cyclopamine accumulates in subterranean organs, these tissues were 
given a value of 20 for the Haystack input while the above ground organs were designated a 
value of 1 in order to create a generalized model for cyclopamine biosynthesis. In our approach, 
the LC-MS/MS alkaloid data for Veratrum is the input model used to search the deep 
transcriptome experimental dataset of Veratrum, correlating metabolite accumulation and gene 
expression data as previously reviewed (Saito et al. 2008). We obtained 3,219 contigs that fit 
the 20:1 subterranean organ:aerial organ cyclopamine accumulation model.  
In addition to identification of genes exhibiting correlating expression patterns with cyclopamine 
accumulation, the protein-coding gene sequences in the Veratrum RNA-seq transcriptome 
dataset were classified into putative gene families using PlantTribes 2.0 
(http://fgp.bio.psu.edu/tribedb/10_genomes/index.pl) (Wall et al. 2008). This dataset was used 
to better define and cluster the Veratrum transcripts that are of most interest to the cyclopamine 
pathway. Cytochromes P450 were chosen from the resulting dataset due to the hypothesized 
oxidative transformations necessary to convert cholesterol into cyclopamine. The alternative 
enzyme class would be 2-oxoglutarate-dependent dioxygenases, if the cytochrome P450 
dataset did not yield positive results. 
Top candidate genes from the Haystack and tribe clustering analysis with the highest homology 
to cytochrome P450 enzymes involved in triterpene and fatty acid hydroxylation/ biosynthesis 
were selected for downstream functional characterization (Table S3). Incorporation of nitrogen 
into the steroid skeleton is required; therefore, aminotransferases fitting the Haystack model 
were also included in the candidate gene list (Table S4). Full-length candidate cDNAs were 
expressed in S. frugiperda Sf9 cells using a baculovirus-based expression system allowing for 
the accommodation of multi-virus infections. S. frugiperda Sf9 cells provide a facile synthetic 
biology platform for the systematic refactoring of plant biosynthetic pathways (Diaz Chavez et al. 
2011).  
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2.5.3 Cholesterol 22-hydroxylase 
The top-scoring candidate cDNAs resulting from interrogation of the V. californicum 
transcriptome dataset were systematically and individually introduced, together with 
Eschscholzia californica cytochrome P450 reductase (CPR), into S. frugiperda Sf9 insect cells, 
which were harvested as previously described and used in enzyme assays with cholesterol as 
substrate (Diaz Chavez et al. 2011, Rosco et al. 1997). Most cytochrome P450 enzymes require 
the addition of a reductase for heterologous expression. In our hands, differences in enzyme 
activity were not dependent on the plant species from which the CPR was derived (Gesell et al. 
2009). Cholesterol was chosen as the initial precursor for study based upon existing knowledge 
of steroid alkaloid biosynthesis (Cordell 1998, Kaneko et al. 1970b). Related compounds were 
also tested to determine enzyme specificity (Table S5). The contig designated 2646, which is 
annotated as a steroid C-22 hydroxylase, added a hydroxyl group to the 22-position of 
cholesterol exclusively in the R orientation as determined by GC-MS (Figure 1; Figure S2 a; 
Figure S3 a). The hydroxylation demonstrated in Figure 1 used extracts of Sf9 cells co-
expressing contig 2646 and E. californica CPR as we have discovered their ability to utilize 
endogenous Sf9 cholesterol as substrate. One variant of 2646 was identified by RT-PCR having 
99.8% identity and catalyzing the same enzymatic reaction. Cytochrome P450 (CYP) 
assignments for both homologs are CYP90B27v1 and CYP90B27v2, where version 
CYP90B27v1, accession KJ869252, was chosen for subsequent analysis. We have designated 
this enzyme cholesterol 22-hydroxylase. CYP90B27 also hydroxylated 26-hydroxycholesterol 
(27(25R)-hydroxycholesterol) and 7β-hydroxycholesterol in the 22-position as determined by 
enzyme assay, but was unable to hydroxylate the 24-methylsterol campesterol, a metabolite 
leading into brassinosteroid biosynthesis (Figure S2 e; Figure S4; Figure S5). CYP90B27 
oxidizes the hydroxyl group at the 22-position to a ketone, but only to a low degree (Figure 1). 
The identity of the enzymatic product of CYP90B27 acting on cholesterol was confirmed by 
comparison to 22(R)-hydroxycholesterol standard. The diastereomers 22(R)- and 22(S)-
hydroxycholesterol are chromatographically resolved by the GC-MS method used (Figure S6). 




2.5.4 22-Hydroxycholesterol 26-hydroxylase/oxidase 
To identify the second enzyme in the pathway, a series of triple infections of S. frugiperda Sf9 
cells were carried out that contained CYP90B27 and E. californica CPR, but varied the second 
enzyme. Candidates for the second enzyme were the remaining top-scoring candidate cDNAs 
resulting from interrogation of the V. californicum transcriptome dataset. Contig 12709, which 
annotated as a fatty acid hydroxylase, was found to hydroxylate 22(R)-hydroxycholesterol at the 
C-26 position forming 22,26-dihydroxycholesterol by GC-MS (Figure 1; Figure S4). This enzyme 
also oxidizes the hydroxyl group at the 26 position creating a highly reactive 22-
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hydroxycholesterol-26-al as detected by LC-MS/MS (Figure S7 a). Four variants were 
generated by RT-PCR with identities ranging from 93–99%; all catalyze the same reaction. 
Hydroxylation of cholesterol by 12709 was not detected (Figure S3); this enzyme was therefore 
designated 22-hydroxycholesterol 26-hydroxylase/oxidase. CYP assignments are CYP94N1v1, 
CYP94N1v2, CYP94N2v1, and CYP94N2v2. In figures and subsequent text, CYP94N1 refers to 
accession KJ869255 which was chosen as the representative variant for this study. The identity 
of 22,26-dihydroxycholesterol produced by action of 12709 on 22(R)-hydroxycholesterol was 
ultimately determined using the 22-hydroxylating activity of CYP90B27 to produce 22,26–
dihydroxycholesterol from pure 26-hydroxycholesterol and comparing the mass spectra of the 
two enzymatic products (Figure S4). 
2.5.5 22-Hydroxycholesterol-26-al transaminase 
To identify the third enzyme in the pathway, a series of quadruple infections of S. frugiperda Sf9 
cells were carried out that contained CYP90B27, CYP94N1, and E. californica CPR, but varied 
the third enzyme. Candidates for the third enzyme were the remaining top-scoring candidate 
cDNAs. A γ-aminobutyric acid (GABA) transaminase (contig 12084) was shown to incorporate 
nitrogen into the 26-position of 22-hydroxycholesterol-26-al using GABA as an amino group 
donor to produce 22-hydroxy-26-aminocholesterol as detected by LC-MS/MS (Figure S8 a). 
Three variants were found by RT-PCR, each with over 99% identity and all able to catalyze the 
same reaction. Evidence for the structure of 22-hydroxy-26-aminocholesterol was obtained by 
high resolution MS (Figure S9). 22-Hydroxy-26-aminocholesterol was not produced in Sf9 
enzyme assays that included CYP90B27, CYP90G1 (see below), GABAT1, and CPR but lacked 
CYP94N1 (Figure S7 b; orange), indicating that addition of nitrogen to position 26 is likely. This 
enzyme was designated 22-hydroxycholesterol-26-al transaminase. In figures and subsequent 
text, GABAT1 refers exclusively to accession KJ89263, the variant chosen for subsequent 
study.GABAT1 was expressed and purified from E. coli and used in enzyme assays to test 
potential co-substrates GABA, L-arginine, and L-glutamine (Figure S10). GABA was the only 
accepted amino group donor. Minor peaks in the L-arginine and L-glutamine assays are likely 
due to GABA present in E. coli (Dhakal et al. 2012). 
2.5.6 22-Hydroxy-26-aminocholesterol 22-oxidase 
Augustin, Megan, 2015, UMSL, p.32 
 
 
To identify the fourth enzyme in the pathway, a series of quintuple infections of S. frugiperda Sf9 
cells were carried out that contained CYP90B27, CYP94N1, GABAT1, and E. californica CPR, 
but varied the fourth enzyme. Candidates for the fourth enzyme were the remaining top-scoring 
candidate cDNAs. Contig 13284 was also annotated as a steroid C-22 hydroxylase, but 
hydroxylation at the 22-position of cholesterol was not readily detected. It was, however, able to 
oxidize an existing hydroxyl group at position 22 to a much greater degree than CYP90B27 as 
shown by GC-MS (Figure 1; Figure S2 b). 13284 oxidizes the 22-hydroxy position of 22(R)-
hydroxycholesterol to form 22-keto-cholesterol (Figure 1), 22,26-dihydroxycholesterol to form 
22-keto-26-hydroxycholesterol (Figure 1; Figure S8 b), and 22-hydroxy-26-aminocholesterol to 
form a short lived intermediate that cyclizes 
to verazine (Figure 2; Figure S8 c). Four 
variants were isolated using RT-PCR, each 
having more than 97% identity and all able to 
perform the same reaction. CYP designations 
for each sequence are: CYP90G1v1, 
CYP90G1v2, CYP90G1v3, and CYP90G2. In 
figures and subsequent text, CYP90G1 refers 
to accession KJ869260 which was selected 
for further analysis. The structures of the 
enzymatic products 22-keto-cholesterol and 
22-keto-26-hydroxycholesterol were 
confirmed by NMR spectroscopy (Data S2). 
The structure of verazine was supported by 
high resolution MS (Figure S9). The enzyme 
was subsequently designated 22-hydroxy-26-
aminocholesterol 22-oxidase. Accession 
numbers and designations for all 
characterized enzymes can be found in Table 
S6. 
2.5.7 Biosynthetic pathway to verazine 
The substrate specificities determined for 
these enzymes suggested a potential 
metabolic grid in the metabolism of 
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cholesterol. CYP90B27 catalyzes the 22-hydroxylation of cholesterol; this is most likely the first 
step in the biosynthesis of steroid alkaloids in V. californicum, confirmed by the inability of 
CYP94N1 and CYP90G1 to accept cholesterol as substrate (Figure S3).  
To establish the pathway order after 22-hydroxylation of cholesterol, a series of enzyme assays 
were carried out using S. frugiperda Sf9 cell extracts containing each individual candidate 
enzyme. The order of addition for each enzyme was varied, and products were analyzed by GC-
MS or LC-MS/MS. The flow chart for both sets of experiments is presented in Figure S11. As 
seen in Figure S12 c and e, 22-keto-26-hydroxycholesterol was only produced at detectable 
levels by CYP90G1 from 22,26-dihydroxycholesterol. CYP94N1 was unable to hydroxylate 22-
keto-cholesterol at levels detected by GC-MS. The ability of CYP90G1 to accept 22,26-
dihydroxycholesterol as substrate and produce 22-keto-26-hydroxycholesterol, along with the 
lack of product detection for CYP94N1 incubated with 22-keto-cholesterol, provided evidence 
that CYP94N1 acted directly after CYP90B27. This evidence was substantiated with another set 
of enzyme assays, beginning with CYP90B27, showing that CYP94N1 produced little product 
when provided with 22-keto-cholesterol (using the increased sensitivity of LC-MS/MS for 
detection) as seen in Figure S7 b; blue, as compared to the large amount of product produced 
when 22,26-dihydroxycholesterol is acted upon by CYP90G1 (Figure S7 a; blue). 
22-Hydroxy-26-aminocholesterol was produced in Sf9 cells by CYP90B27, CYP94N1, GABAT1, 
and CPR in the presence or absence of CYP90G1 (Figure S8 a; c). GABAT1, therefore, did not 
require a 22-ketone moiety on the substrate. When CYP90B27 acted in the presence of 
CYP94N1, several side products were detected in addition to 22,26-dihydroxycholesterol 
(Figure S7 a; red). These compounds included 22-keto-26-hydroxycholesterol, 22-
hydroxycholesterol-26-al and two unidentified products. Since an amino group was not added to 
the 22-ketone moiety of 22-keto-26-hydroxycholesterol, 22-keto-26-hydroxycholesterol most 
likely does not participate in this steroid alkaloid pathway. The short lived and highly reactive 22-
hydroxycholesterol-26-al must therefore be the substrate of GABAT1. After an amino group is 
transferred to the C-26 aldehyde, CYP90G1 oxidizes the C-22-hydroxyl moiety to a ketone, and 
cyclization to verazine occurs (Figure 2; Figure S8 c).  
Evidence for the short-lived intermediate 22-hydroxycholesterol-26-al was obtained by 
dimedone aldehyde trapping (Figure S13). The amino group is added prior to oxidation of the C-
22 hydroxyl group; therefore, the amino group must be transferred to a C-26 aldehyde. The 
structure of the predicted cyclic imine verazine was supported by borohydride reduction of the 
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double bond (Figure S14) and exact mass analysis as demonstrated by high resolution MS 
(Figure S9).  
The biosynthetic pathway proposed herein (Figure 3) is similar to a hypothesized pathway 
presented in earlier studies of steroid alkaloids in the genus Veratrum. We found, however, that 
22-keto-26-hydroxycholesterol (dormantinone) was not readily accepted as substrate for 
GABAT1, as verazine was not formed when supplied this compound (Figure S7 a; purple). In 
contrast, verazine was formed when 22-hydroxy-26-amino-cholesterol was supplied to 
CYP90G1 (Figure S7 a; green). In further support of our proposed pathway, the biosynthetic 
intermediates 22-hydroxy-26-aminocholesterol, 22-keto-26-hydroxycholesterol, and verazine 
were detected in V. californicum extracts by LC-MS/MS (Figure S15) and the distribution of 
these intermediates followed the same accumulation pattern as cyclopamine (Figure S1). 22,26-
Dihydroxycholesterol (dormantinol) and verazine have also been previously detected in steroid 
alkaloid producing Veratrum species and hypothesized to be intermediates in steroid alkaloid 
biosynthesis (Adam et al. 1967, Kaneko et al. 1977).  
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2.5.8 Site of steroid alkaloid biosynthesis in V. californicum 
A comparison was made between biosynthetic gene expression profiles and cyclopamine 
accumulation in V. californicum (Figure 4). A pattern emerged that indicates biosynthetic genes 
are most highly expressed in root, bulb, and spring rhizome, while cyclopamine (Figure 4; 
Figure S1) is highest in spring- and fall rhizome. The hypothesized intermediates 22-hydroxy-
26-aminocholesterol, 22-keto-26-hydroxycholesterol, and verazine follow a similar trend with 
highest accumulation in root, spring- and fall rhizome (Figure S15). Moreover, the higher level of 
cyclopamine in fall rhizome compared to spring rhizome suggests an accumulation of the 
steroid alkaloid during rhizome growth in summer (Figure S1). Interestingly, fall rhizome has 
significantly more cyclopamine relative to transcript level; the opposite is true for bulb (Figure 4). 





The evolutionary origin of specialized metabolism like that in the Veratrum genus is of particular 
interest not only for understanding species divergence but also for the recognition of additional 
species containing related compounds with potential therapeutic value. Biochemical analysis of 
the Veratrum steroid alkaloid pathway herein alongside a recently proposed biosynthetic 
pathway for steroid glycoalkaloids in Solanum lycopersicum (Itkin et al. 2013) suggests 
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independent origins of the Solanum steroid alkaloids and the Veratrum steroid alkaloids. In S. 
lycopersicum, initial transformations of cholesterol include C-22 hydroxylation followed by C-26 
hydroxylation and closure of the E-ring. Oxidation at C-26 and subsequent transamination at 
that position occur without the formation of the intermediate verazine. In conjunction with our 
results, previous work on steroid alkaloid formation in Veratrum does not support E-ring closure 
prior to aldehyde formation and transamination (Kaneko et al. 1970a, Kaneko et al. 1975, 
Kaneko et al. 1977, Kaneko et al. 1976). Verazine production requires formation of the F-ring 
following transamination prior to E-ring closure. If the pathway was identical to that proposed in 
S. lycopersicum, E-ring closure prior to amination would not allow for the formation of verazine. 
Oxidation at C-26 by the multifunctional CYP94N1 may be the gateway reaction when 
comparing the point of divergence between the two pathways. This oxidation in Veratrum allows 
for the immediate addition of nitrogen, leading to F-ring closure and verazine formation. In 
contrast, the action of GAME11, the 2-oxoglutarate-dependent dioxygenase in the Solanum 
pathway, in conjunction with other unidentified enzymes after C-26 hydroxylation, leads to 
closure of the E-ring prior to C-26 oxidation and nitrogen addition. The possibility exists that 
multiple steroid alkaloid biosynthetic pathways occur in one or both families and those 
respective genes are yet to be discovered, as solanidine-type and verazine-like compounds 
have been identified in both members of the Liliaceae and Solanaceae (Cordell 1998). 
The independent origin of the two pathways is further corroborated by the phylogenetic 
relationship of the enzymes involved. A phylogenetic analysis of select cytochrome P450 
enzymes, including several involved in steroid metabolism (Figure 5, Table S7), demonstrates 
this distinction. CYP90B27 in V. californicum and CYP72A186 (GAME7), the proposed 
cholesterol 22-hydroxylase in S. lycopersicum, are in distinct pan-angiosperm clades suggesting 
recruitment from separate P450 subfamilies; likewise for CYP72A208 (26-hydroxylase in S. 
lycopersicum, GAME8) and V. californicum CYP94N1. Similarly, CYP88B1 (GAME4), the S. 
lycopersicum enzyme that performs oxidation at position 26, falls into a well-supported clade 
distinct from the clade containing CYP94N1. The phylogenetic placement of these enzymes 
alludes to potential convergent evolution of these genes. The similarity of V. californicum 
enzymes CYP90B27 and CYP90G1 with the CYP90B1s, enzymes known to participate in 
primary brassinosteroid metabolism, may be indicative of steroid alkaloid biosynthesis evolution, 
in part, deriving from the brassinosteroid pathway. 
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An in-depth phylogenetic analysis (Figure S16, Table S8) of the steroid modifying genes from V. 
californicum and S. lycopersicum alongside homologous cytochrome P450 genes taken from 
transcriptome assemblies generated by the 1KP and MonAToL sequencing projects (Data S1) 
substantiate the hypothesis of independently derived pathways. Three major cytochrome P450 
clades emerge. Both V. californicum CYP90B27 and CYP90G1 are localized in Clade 1. Clade 
1 contains a number of ancient gene duplications that show evidence of paralog retention with 
expression of multiple copies within species, especially in monocots. In agreement with Figure 
5, SlCYP90B1 falls into the same well-supported subclade as these two Veratrum genes with 
CYP90B27 being more closely related to SlCYP90B1. Clade 2 contains the S. lycopersicum 
genes GAME6, GAME7, and GAME8, but no sampled Veratrum genes. Interestingly, this clade 
shows several eudicot gene duplications, most likely genome-specific tandem duplications that 
are not observed in the monocot species included in this study. V. californicum CYP94N1 is 
found in Clade 3. Clade 3 appears to be the least diverse of the three P450 clades containing 
multiple copies of homologs only in a few taxa, potentially related to whole genome duplication 
events. 
We functionally investigated the relatedness of the V. californicum GABAT1 that incorporates 
nitrogen into 22-hydroxycholesterol-26-al and the S. lycopersicum GABA transaminase isozyme 
2 involved in steroid alkaloid biosynthesis. These enzymes share 64% identity at the amino acid 
level. Due to the similarities of the two pathways, we tested whether S. lycopersicum GABA 
transaminase isozyme 2 can incorporate nitrogen into 22-hydroxycholesterol-26-al. We 
demonstrated that S. lycopersicum GABA transaminase isozyme 2 was able to convert 22-
hydroxycholesterol-26-al to 22-hydroxy-26-aminocholesterol and, in conjunction with CYP90G1, 
resulting in subsequent cyclization to verazine (Figure S8 d). S. lycopersicum GABA 
transaminase isozyme 2 was used as query to BLAST the V. californicum transcriptome; the 
best hit was another transaminase, contig 674. 674, designated GABAT2, has 68% identity to S. 
lycopersicum GABA transaminase isozyme 2 and 69% identity to V. californicum GABAT1 at 
the amino acid level. Despite the sequence homology to both V. californicum GABAT1 and S. 
lycopersicum GABA transaminase isozyme 2, GABAT2 was unable to convert 22-
hydroxycholesterol-26-al to 22-hydroxy-26-aminocholesterol at detectable levels (Figure S17).  
Overall, our data indicates that CYP90B27, CYP94N1, CYP90G1, and GABAT1 catalyze the 
first six steps of steroid alkaloid biosynthesis in V. californicum to form verazine, a proposed 
intermediate of the antineoplastic cyclopamine. We refactored the pathway to verazine in S. 
frugiperda Sf9 cells by infections with viruses containing each gene, thereby demonstrating 
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gene-product function. Verazine exhibits strong antifungal properties and can serve as a 
synthon for the synthesis of bioactive molecules with additional pharmaceutical properties 
including liver protection and anti-tumor activities (Gan et al. 1993, Jiang et al. 2005, Kusano et 
al. 1987, Zhou 2003). We also demonstrated that the precursor in this pathway is 22(R)-
hydroxycholesterol rather than 22(S)-hydroxycholesterol, as previously proposed (Kaneko et al. 
1977). Our data suggests that dormantinone is not an intermediate in the formation of verazine, 
and the amino donor for GABAT1 is GABA rather than L-arginine or L-glutamine (Kaneko et al. 
1976).  
The candidate gene selection criteria with emphasis on clades that contained only Veratrum 
genes fitting the Haystack model increased our rate of gene identification. Of the 3,219 genes 
fitting the Haystack model, 9 cytochrome P450 genes were assigned high priority for 
biochemical characterization. Seven were tested; 3 catalyzed the first reactions in the verazine 
biosynthesis pathway. Likewise, 3 GABATs were prioritized for functional characterization; 1 
GABAT was found to participate in the verazine pathway. Based upon the success of this 
methodology, we expect continued, facile elucidation of this and other biochemical pathways 
from non-model systems. 
2.7 Experimental procedures 
Plant material and RNA extraction 
See Method S1 and Table S9. 
Liquid chromatography mass spectrometry (LC-MS/MS) method 
Samples were first extracted with either ethanol (see Method S2) for plant tissue or ethyl 
acetate for Sf9 cell suspensions and enzymatic assays. Liquid chromatographic separation was 
achieved with 10 µl injections on a LC-20AD (Shimadzu) LC system coupled to a 4000 QTRAP 
(AB Sciex Instruments) for MS/MS analysis. Separation was achieved using a Phenomenex 
Gemini C-18 NX column (150 X 2.00 mm, 5 µm) with a flow rate of 0.5 ml/min and the following 
gradient program [solvent A (0.05% formic acid/0.04% ammonium hydroxide (25%) v/v in H2O; 
solvent B (0.05% formic acid/0.04% ammonium hydroxide (25%) v/v in 90% acetonitrile]: 
Solvent B was held at 20% for 2 min, then 2-11 min 20-30% B, 11 – 18 min 30-100% B, 18-22 
min 100% B, 22-23 min 100-20% B, and held at 20% B for an additional 5 minutes. Program 
parameters included a TurboIonSpray ionization source temperature of 500°C and low 
resolution for Q1 and Q3 done with MRM (Multiple Reaction Monitoring) scans in the positive 
ion mode. Specific ion fragments and parameters can be found in Table S10. In conjunction, 
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EMS (Enhanced MS) scan with a mass range of 380 to 425 m/z, and EPI (Enhanced Product 
Ion) scans for 398, 417, and 418 m/z were included. Compound identification was determined 
by comparison of retention time and fragmentation pattern to the authentic standard 
cyclopamine (Infinity Pharmaceuticals) (where applicable). Quantitation was performed by 
plotting peak area versus pmol of standard using Analyst 1.5 (Applied Biosystems).  
Gas chromatography mass spectrometry (GC-MS) method 
Samples were first extracted with either hexane:isopropanol 3:2 followed by hexane only or 
ethyl acetate. Dried extracts were derivatized with 40 µl Sylon HTP (Sigma) for 1 hour at 90°C 
prior to injection with a 7683B autosampler onto a 7890A gas chromatograph coupled to a 
5975C mass spectrometer inert XL MSD with triple-axis detector (Agilent Technologies). Both 
full scan and SIM methods were run in the splitless mode with 1 µl injection volume and a flow 
rate of 1 ml/min with helium as the carrier gas. Separation was performed on a Zebron ZB-5MSi 
column (Phenomenex) with guardian 5M (30 m x 0.25 mm x 0.25 µm) with 5% Polysilarylene - 
95% Polydimethylsiloxane copolymer composition and 106 relative voltage. The initial 
temperature of 240°C was held for 5 minutes and increased to 300°C at a rate of 10°C/min and 
held for 25 minutes. The full scan method measured mass from 50 to 800 amu and ions 
detected in the SIM mode included: 99.1, 129, 165, 171, 173.1, 187, 261, 314.1, 329.3, 330, 
370, 382.3, 417.4, 456.4, 458, 460, 470, 472.3, 486, 546, 560, and 634.  
Veratrum californicum metabolite extraction for quantitation by LC-MS/MS 
See Method S2. 
Transcriptome assembly and determination of relative contig expression 
cDNA library construction, Illumina paired-end sequencing, and de novo transcriptome 
assembly were performed at the National Center for Genome Resources (Santa Fe, New 
Mexico). Please refer Method S3 for transcriptome assembly details. 
Transcriptome dataset interrogation using Haystack and Plant Tribes  
Identification of genes whose expression pattern correlated with accumulation of cyclopamine 
was determined using the Haystack program (Michael et al. 2008, Mockler et al. 2007). The LC-
MS/MS cyclopamine quantitation data for the different V. californicum tissues was used to 
formulate a model based upon the ratio of biosynthetic tissues. 95 % of the total cyclopamine 
was found in the subterranean tissues (root, bulb, and rhizome) whereas 5 % was found above 
ground (leaf, shoot, and flower). For the input model, each subterranean tissue was given a 
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value of 20 and all above ground tissues including the tissue culture samples was designated 1. 
Parameters for Haystack were as follows: correlation cut off = 0.7 fold change = 2, p-value = 
0.05 and background = 1. Due to the large data input, Haystack analysis was performed on a 
UNIX server in-house as opposed to the version available online. Annotation data was then 
merged with the gene outputs from each of the models. Subsequent alignments and 
phylogenetic analysis were performed using Muscle algorithm (Edgar 2004) and Mega v6.06 
(Tamura et al. 2011). See Method S4 for dataset interrogation using PlantTribes and a detailed 
description of methods for contig prioritization.  
Construction of viral expression vectors 
Candidate contigs obtained from Haystack and phylogenetic analysis were subjected to BLAST 
searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and global alignments to homologous, 
experimentally characterized gene sequences with the CLC Main Workbench 6.8, for prediction 
of the open reading frame. Where the reading frame appeared incomplete, Rapid Amplification 
of cDNA Ends (RACE) was used to obtain the complete coding sequence. V. californicum cDNA 
was prepared from root RNA extracts using M-MLV Reverse Transcriptase (Invitrogen) 
according to manufacturer’s instructions. All primer sequences and PCR programs can be found 
in Table S11 and S12, respectively. Please refer to Method S5 for specific cloning details. 
Virus co-transfection, amplification, and protein production 
See Method S6 and Table S13. 
Extraction of multiple infections for Sf9 in vivo product production  
See Method S7. 
Enzyme assays 
Each cytochrome P450 co-expressed with CPR in S. frugiperda Sf9 cells and GABAT1 was 
subjected to individual enzyme assays with the compounds designated in Table S5 including 
cholesterol (Sigma Aldrich), 22(R)-hydroxycholesterol (Sigma Aldrich), 26-hydroxycholesterol 
[27(25R)-hydroxycholesterol] (Avanti Polar Lipids Inc.), 22(S)-hydroxycholesterol (American 
Radiolabeled Chemicals), 24(S)-hydroxycholesterol (American Radiolabeled Chemicals), 4β-
hydroxycholesterol (Research Plus Inc.), 7β-hydroxycholesterol (Sigma Aldrich), campesterol 
(Avanti Polar Lipids Inc.), β-sitosterol (Sigma Aldrich), stigmasterol (Sigma Aldrich), GABA 
(Sigma Aldrich), L-arginine (Sigma Aldrich), and L-glutamine (Sigma Aldrich) to determine 
substrate specificity. Compounds were prepared to 1 mM stock solutions of 100% DMSO and 
diluted with H2O, except for the amino acids, which were prepared as 200 mM stocks in pure 
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H2O. For GC-MS analysis, 5 individual assays per substrate were pooled after incubation at 
30°C for 2 hours; one assay produced sufficient product for analysis by LC-MS/MS. Assay 
conditions were as follows: 80 µl S. frugiperda Sf9 cell suspension (obtained by re-suspension 
of 50 ml viral infected culture pellet in 3.5 ml of 100 mM tricine pH 7.4/ 5 mM thioglycolic acid), 
60 mM potassium phosphate buffer pH 8, 1.25 mM NADPH, 7.5 µM substrate, and H2O in a 
total volume of 200 µl. Controls were performed with no enzyme and S. frugiperda Sf9 cells 
expressing an unrelated cytochrome P450 (CYP719A14 cheilanthifoline synthase from 
Argemone mexicana), or CPR-only, for each assay.  
The initial GABAT1 enzyme assay contained 55 µl S. frugiperda Sf9 cell suspension infected 
with CYP90B27, CYP94N1, CYP90G1, and CPR modified baculoviruses (to provide 22-
hydroxycholesterol-26-al substrate), 40 µl S. frugiperda Sf9 cells expressing GABAT1, 60 mM 
potassium phosphate buffer pH 8, 1.5 mM DTT, 100 µM pyridoxal-5-phosphate (PLP), 16 mM 
GABA, 500 µM NADPH, and H2O to a total volume of 200 µl. Assay mixes lacking either 
enzyme or GABA, and control cytochrome P450 assays were run in parallel and each was 
allowed to proceed for 2 hours at 30°C. Samples were extracted twice with 400 µl ethyl acetate. 
For determination of the amino group donor, assays were prepared as above for GABAT1 with 
the following exceptions. The GABAT1 gene was cloned into the EcoRI/NdeI sites of pET28a 
and expressed in E.coli PlusE cells. The GABAT1 protein was purified in the presence of 2 
µg/ml PLP using TALON metal affinity resin (Clontech) and PD-10 desalting columns (GE 
Healthcare) according to manufacturer’s instructions to obtain purified enzyme. The substrate 
22-hydroxycholesterol-26-al was obtained by extracting 2 ml of Sf9 cells expressing CYP90B27, 
CYP94N1, and CPR with 2 volumes of ethyl acetate and dried with N2. The dried extract was 
resuspended in 400 µl of 10% DMSO. Assays were performed in duplicate and each run with 
22-hydroxycholesterol-26-al and either GABA, L-arginine, or L-glutamine alongside CPR only 
controls and controls using GABAT1 expressed in Sf9 cells. Samples were then dried under N2, 
re-suspended in 50-100 µl 80% methanol, and injected onto LC-MS/MS with conditions 
described above. All cytochrome P450 enzyme assays utilized crude S. frugiperda Sf9 protein 
extracts that contain endogenous metabolites, including cholesterol. 
Assays to clarify order of enzymatic transformations 
See Method S8 and Figure S11. 
Enzymatic product purification for NMR and High Resolution MS for structure elucidation 
See Method S9 and Data S2. 
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Dimedone aldehyde trapping 
Enzyme assays containing CYP94N1 and 22(R)-hydroxycholesterol as substrate, or CYP90B27 
+ CYP94N1 utilizing endogenous cholesterol in S. frugiperda Sf9 cells as substrate, or 
CYP90B27 + CYP94N1 and GABAT1, also utilizing endogenous cholesterol in S. frugiperda Sf9 
cells as substrate with either 80 µl 10 mg/ml dimedone in 10% DMSO or 80 µl 10% DMSO were 
incubated overnight at 30°C. Assays were extracted twice with 2 volumes ethyl acetate and 
analyzed by LC-MS/MS. All cytochrome P450 enzymes were co-expressed with CPR. 
Sodium borohydride reduction 
2 ml S. frugiperda Sf9 cells expressing CYP90B27 + CYP94N1 + GABAT1 + CYP90G1 + CPR 
were extracted twice with equal volume ethyl acetate. Extracts were divided equally, dried under 
N2, and re-suspended in 50 µl 80% methanol each. One sample was treated with 50 µl 1 M 
NaBH4 in 1 M NaOH for 15 minutes. 100 µl H2O were added to both samples, and each 
extracted twice with equal volumes of chloroform. Samples were dried under N2, re-suspended 
in 50 µl 80% methanol and analyzed by LC-MS/MS as described above. S. frugiperda Sf9 cells 
expressing CPR only were run in parallel as control. 
Phylogenetic analysis of cytochrome P450 enzymes across species using deep 
transcriptome sequence data from 1KP and MonAToL projects 
See Method S10 and Table S8. 
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2.9.1 Supporting figures 
 






























































Figure S16. Phylogenetic tree of cytochrome P450 enzymes using transcriptome data 
from 1KP and MonAToL sequencing projects. The maximum likelihood tree depicting 
relationships of P450 genes from across angiosperms and other land plants demonstrates 
conservation of ancient diversification within gene families. Both ancient and recent gene 
duplications arise within angiosperms with the P450 gene family. Sequences were obtained by 
alignment of Veratrum californicum P450 enzymes CYP90B27, CYP90G1, and CYP94N1, and 
the S. lycopersicum genes GAME4, GAME 6, GAME 7, and GAME 8 to homologous sequences 
found in the 1kP and MonAToL sequencing projects. Refer to Table S8 for species key and 
sequence source. 
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2.9.2 Supporting tables 
 
Table S1. Sequence reads and length generated for each RNA sample (paired end).  
Tissue Used for RNA Sequence Reads Per File Average Read Length 
Bulb  8,870,015 50 
Flower 10,499,190 50 
Leaf 8,811,375 50 
Fall Rhizome  10,558,614 50 
Spring Rhizome  11,237,164 50 
Fall Roots 8,026,623 50 
Green Shoots 10,021,063 50 
White Shoots 10,563,408 50 
Tissue Culture Week 1 9,946,944 50 
Tissue Culture Week 2 12,413,973 50 
 
Table S2. Transcriptome statistics provided by the NCGR. 
Sequences 56994 
Bases 41106915 
Minimum length 100 
Maximum length 16273 
N50 1471 
B1000* 64.4% 





*B1000 is the percent of scaffolds greater than 1000 bases and **B2000 is the percent of 
scaffolds greater than 2000 bases. 
Table S3. Selected top-scoring cytochrome P450 candidate cDNAs for the enzymatic 
conversion of cholesterol to cyclopamine. 
Gene ID Putative function 
>medp_verca-20110208|2398 similar to CYP71D unknown function* 
>medp_verca-20110208|31930 similar to CYP71D unknown function 
>medp_verca-20110208|10041 similar to CYP728 taxane 13a-hydroxylase* 
>medp_verca-20110208|13942 similar to CYP734 brassinolide C-26 hydroxylase* 
>medp_verca-20110208|13284 similar to CYP90B1 steroid C-22 hydroxylase*+ 
>medp_verca-20110208|18017 similar to CYP90B1 steroid C-22 hydroxylase 
>medp_verca-20110208|18580 similar to CYP90B1 steroid C-22 hydroxylase*+ 
>medp_verca-20110208|2646 similar to CYP90B1 steroid C-22 hydroxylase* 
>medp_verca-20110208|32399 similar to CYP90B1 steroid C-22 hydroxylase 
>medp_verca-20110208|12709 similar to CYP94D unknown function* 
 
*indicates contigs that were successfully cloned and tested 
+contigs are homologs, and exhibited the same function 
Table S4. Selected top-scoring transaminases in the steroid alkaloid biosynthetic pathway to 
cyclopamine. 
Gene ID Putative function 
>medp_verca-20110208|12217 aminotransferase ACS10 
>medp_verca-20110208|12084 gamma aminobutyrate transaminase 1, mitochondrial-like* 
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>medp_verca-20110208|5285 1-aminocyclopropane-1-carboxylate synthase 
>medp_verca-20110208|28717 aminotransferase ACS12-like* 
>medp_verca-20110208|15871 histidinol-phosphate aminotransferase, chloroplastic-like* 
>medp_verca-20110208|10159 cysteine desulfurase 1 
>medp_verca-20110208|1461 methionine S-methyltransferase 
 
*indicates contigs that were successfully cloned and tested. 
 
Table S5. Substrate testing for cytochrome P450 enzymes co-expressed with CPR. Production 
of a detectable product is indicated by a (+). CYP90B27 refers to cholesterol 22-hydroxylase, 
CYP90G1 refers to 22-hydroxy-26-aminocholesterol 22-oxidase, and CYP94N1 refers to 22-
hydroxycholesterol 26-hydroxylase/oxidase. 
 CYP90B27 CYP90G1 CYP94N1 
cholesterol + - - 
22(R)-hydroxycholesterol + + + 
22(S)-hydroxycholesterol - - - 
26-hydroxycholesterol + - N/A 
22,26-dihydroxycholesterol N/A + N/A 
22-keto-cholesterol N/A N/A - 
4β-hydroxycholesterol - - - 
7β-hydroxycholesterol + - - 
24(S)-hydroxycholesterol - - - 
campesterol - N/A N/A 
β-sitosterol - N/A N/A 
stigmasterol - N/A N/A 
 
Table S6. Assigned enzyme names. 






CYP designation Accession numbers 
Assigned name 
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Table S7. Accession numbers and both putative and determined function for sequences in 
cytochrome P450 phylogenetic tree. 






















AB231153 Steroid 23-alpha-hydroxylase 
OsCYP90A3 Oryza sativa  AB206580 Brassinosteroid c-23-hydroxylase 
AtCYP90B1 Arabidopsis AF412114 Steroid 22-alpha-hydroxylase 
















































































XM_004251512.1 Steroid 26-oxidase 
ZmCYP88A1 Zea mays NM_001112116.1 Early step in gibberellin biosynthesis 


















NM_129002.2 C-22 sterol desaturase 




BT015841.1 Converts JA-Ile to 12-hydroxy-JA-Ile 
PpCYP94C 
Physcomitrell
a patens  






























NM_125276.2 Fatty acid omega-hydroxylase 
OsCYP714B1 Oryza sativa NM_001067187.1  Gibberellin 13-oxidase 
OsCYP714AD
1 
Oryza sativa AY987039.1 
16-Alpha 17-epoxidation on non-13-









Steroid 26-hydroxylase; 26-hydroxylase 
for brassinolide and castasterone 
OsCYP74A3 Oryza sativa NM_001052842.1 Converts 13-hydroperoxylinolenic acid to 
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12,13-epoxylinolenic acid  




































































 HQ439599.1 Costunolide synthase 
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NM_001247334.1 6-Deoxocastasterone oxidase 














Diterpene oxidation to form the diterpene 
resin acids isopimaric acid and abietic 
acid 
 
Table S8. Species key and source for sequences in P450 phylogenetic tree using deep 
transcriptome sequence data from 1KP and MonAToL projects (Al-Mssallem et al. 2013, D'Hont 
et al. 2012). 
Species Source 
Zinnia elegans Genbank (Table S7) 
Nicotiana plumbaginifolia Genbank (Table S7) 
Nicotiana tabacum Genbank (Table S7) 
Vigna radiata Genbank (Table S7) 
Glycyrrhiza uralensis Genbank (Table S7) 
Vicia sativa Genbank (Table S7) 
Artemisia annua Genbank (Table S7) 
Arabidopsis thaliana Genbank (Table S7) 
Medicago truncatula Genbank (Table S7) 
Oryza sativa Genbank (Table S7) 
Physcomitrella patens Genbank (Table S7) 
Populus trichopoda Genbank (Table S7) 
Lotus japonicus Genbank (Table S7) 
Selaginella moellendorffii Genbank (Table S7) 
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Solanum lycopersicum Genbank (Table S7) 
Solanum tuberosum Genbank (Table S7) 
Borya sphaerocephala 1KP 
Chlorogalum pomeridianum 1KP 
Curculigo sp.  1KP 
Cyanastrum cordifolium 1KP 
Eriospermum lancifolia 1KP 
Freycinetia multiflora 1KP 
Goodyera pubescens 1KP 
Helonia bullata 1KP 
Hesperaloe parviflora 1KP 
Johnsonia pubescens 1KP 
Maianthemum canadense 1KP 
Nolina atopocarpa 1KP 
Oncidium spacelatum 1KP 
Platanthera clavellata 1KP 
Ruscus sp.  1KP 
Sansevieria trifasciata 1KP 
Xeronema callistemon 1KP 
Xerophyllum asphodeloides 1KP 
Xerophyta villosa 1KP 
Yucca brevifolia 1KP 





Cirad (D'Hont et al. 
2012) 
Nelumbo nucifera GB: GCA_000365185.2 
Phoenix dactylifera 
JCGR (Al-Mssallem et 
al. 2013) 
Acorus americana MonAToL 
Anemarrhena asphodeloides MonAToL 
Aphyllanthes monspeliensis MonAToL 
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Asparagus asparagoides MonAToL 
Behnia reticulata MonAToL 
Cypripedium acaule MonAToL 
Doryanthes excelsa MonAToL 
Hemiphylacus alatostylus MonAToL 
Ixiolirion sp. MonAToL 
Lanaria larata MonAToL 
Lilium superbum MonAToL 
Paphiopedilum callosum MonAToL 







Aquilegia coerulea Phytozome 
Arabidopsis thaliana Phytozome 
Carica papya Phytozome 
Fragaria vesca Phytozome 
Glycine max Phytozome 
Medicago truncatula Phytozome 
Mimulus guttatus Phytozome 
Oryza sativa Phytozome 
Populus trichopoda Phytozome 
Selaginella moellendorffii Phytozome 
Solanum lycopersicum Phytozome 
Solanum tuberosum Phytozome 
Sorghum bicolor Phytozome 
Theobroma cacao Phytozome 
Vitis vinifera Phytozome 
Veratrum californicum This Study 
 
Table S9. LS/MS rooting medium was prepared with the following concentrations and brought 
to a final pH of 5.75. 
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Macronutrients Supplier Final Concentration (mg/l) 
NH4NO3 Phytotechnology laboratories 1650 
KNO3 Sigma 1900 
MgSO4 x 7H2O Sigma 370 
KH2PO4 Sigma 170 
CaCl2 x 2H2O Sigma 440 
Iron   
Na2EDTA x 2H2O Sigma 37.3 
FeSO4 x 7H2O Sigma 27.8 
Micronutrients   
H3BO3 Sigma 6.2 
MnSO4 x H2O Phytotechnology laboratories 16.9 
ZnSO4 x 7H2O Sigma 8.6 
KI Sigma 0.83 
Na2MoO4 x 2H2O Phytotechnology laboratories 0.25 
CuSO4 x 5H2O Sigma 0.025 
CoCl2 x 6H2O Sigma 0.025 
Vitamines   
Thiamine HCl Sigma 0.1 
Nicotinic acid Sigma 0.5 
Pyroxidine HCl Sigma 0.5 
Myo-inositol Sigma 100 
Other   
Sucrose Phytotechnology laboratories 30000 
1-Naphthaleneacetic acid Phytotechnology laboratories 0.5 
Gelzan Phytotechnology laboratories 3000 
 
Table S10. LC-MS/MS Q-TRAP 4000 method parameters. 





Cyclopamine 412 321 100 120 40 
 412 394 100 120 40 





417 271 100 70 30 
 417 253 100 70 30 
22-Hydroxy-26-
aminocholesterol 
418 400 100 70 30 
 418 382 100 70 30 
Verazine 398 253 100 70 60 
 398 159 100 70 60 
 
Table S11. Primer sequences. 
Number Primer Position and Application 5’ – 3’ Sequence  
1 5’ UTR outer for 2646 CAAGTCGTGATTGATGGCTTTAGAAGGCA 
2 5’ UTR inner for 2646 TGGATCTCTGAAGCCATGAATCGCTAGTA 
3 3’ UTR outer for 2646 TCCTATAACCATTTATTTCTCGTAACC 
4 3’ UTR inner for 2646 ATGCAGAGAGCAATATTACAACCCAA 
5 
5’ gene specific primer (GSP) 
used to amplify 2646 and 




3’ used to amplify 2646 and 
introduce BamHI RS 
TGAGGATCCTTAGTCTCCGAGGGGGCGAACTT 
7 5’ UTR for 13284 AGAAAGAAAGAGAGAGAGATGACTCCA  
8 3’ UTR for 13284 TAGAGAAAGACTGCTTGAATTTTTCAGGCAA 
9 
5’ used to amplify 13284 and 




3’ used to amplify 13284 and 
introduce XbaI RS 
GGGTCTAGATTATTGGAGGAGCGAAAGCCG 
11 
5’ used to amplify 12084 and 




3’ used to amplify 12084 and 
introduce EcoRI RS 
GGGGAATTCTTAAGTTGCGGTATTCTGAGACT
GG 
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13 5’ outer RACE for 12709 GCACTGGAGCACGAGGACACTGA 
14 5’ inner RACE for 12709  GGACACTGACATGGACTGAAGGAGTA 
15 
Outer gene specific internal 
reverse for 12709 5’ RACE 
TGGTCCACCACGTGCGGCCGCGACGAGA 
16 
Inner Gene specific internal 
reverse for 12709 5’ RACE  
GAACCAGGTGAGCGCCGAGGGGGTGGT 
17 
5’ used to amplify 12709 and 
introduce BglII RS 
GGGAGATCTATGGATCTACCCTCCGCCTC 
18 
3’ used to amplify 12709 and 




5’ used to amplify tomato GABAT2 




3’ used to amplify tomato GABAT2 




5’ used to amplify 674 and 
introduce PstI RS 
CACACTGCAGATGTTCTCAAGGCAAGCTACAG 
22 
3’ used to amplify 674 and 




5’ used to amplify 12084 for 
insertion into pET28a and 
introduce NdeI RS 
TTTCATATGGGATCCACTGAGGCGCCTGTAT 
24 
3’ used to amplify 12084 for 
insertion into pET28a and 




Table S12. PCR Parameters. 
2646 for TOPO cloning, VC2646 for pVL1392 
cloning, VC12709 for pVL1392 cloning, 
VC13284 TOPO cloning 
98°C for 30 sec, then 35 cycles of 98°C for 10 
sec, 60°C for 30 sec, 72°C for 1 min 30 sec, 
and a final 10 min extension at 72°C 
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12709 5’ RACE 98°C for 30 sec, then 35 cycles of 98°C for 10 
sec, 65°C for 30 sec, 72°C for 1 min and a 
final 10 min extension at 72°C 
13284 for pVL1392 cloning 98°C for 30 sec, then 35 cycles of 98°C for 10 
sec, 63°C for 30 sec, 72°C for 1 min 25 sec, 
and a final 10 min extension at 72°C 
12084 for pVL1392 cloning 98°C for 30 sec, then 35 cycles of 98°C for 10 
sec, 60°C for 30 sec, 72°C for 1 min, and a 
final 10 min extension at 72°C 
Tomato GABAT and 674 for pVL1392 cloning 98°C for 30 sec, then 35 cycles of 98°C for 10 
sec, 62°C for 30 sec, 72°C for 45 sec, and a 
final 10 min extension at 72°C 
12084 for pET28a cloning 98°C for 30 sec, then 35 cycles of 98°C for 10 
sec, 63°C for 30 sec, 72°C for 2 min, and a 
final 10 min extension at 72°C 
 
Table S13. Viral combinations for in vivo production of metabolites in S. frugiperda Sf9 cells. 
Combination Viruses  
Combination 1 CYP90B27, CPR 
Combination 2 CYP94N1, CPR 
Combination 3 CYP90G1, CPR 
Combination 4 CYP90B27, CYP94N1, CPR 
Combination 5 CYP90B27, CYP90G1, CPR 
Combination 6 CYP90B27, CYP94N1, CYP90G1, CPR 
Combination 7 
CYP90B27, CYP94N1, CYP90G1, GABAT1, 
CPR 
Combination 8 CYP90B27, CYP94N1, GABAT1, CPR 




CYP90B27, CYP94N1, CYP90G1, GABAT2, 
CPR 
Combination 10 
CYP90B27, CYP94N1, CYP90G1, S. 
lycopersicum GABAT2, CPR 
 
2.9.3 Supporting data 
Data S1. Data access for sequence information. 
Illumina reads and assembled transcriptome retrieval of Veratrum californicum, 
Narcissus sp. aff. pseudonarcissus, and Colchicum autumnale. 
Each species was assembled by the NCGR and the raw reads, assembled transcriptome, and 
readme files can be found at: http://www.medplantrnaseq.org/. 
Data access for 1KP and MonATol Projects. 
Data for the 1KP can be accessed at https://sites.google.com/a/ualberta.ca/onekp/ 
Data for the MonATol project is currently unpublished and access to the sequence information 
was courtesy of James H. Leebens-Mack (jleebensmack@plantbio.uga.edu). All sequences and 
alignments used in this analysis are deposited in Dryad: DOI: doi:10.5061/dryad.n9s7q. 
Data S2. NMR designations for 22-keto-cholesterol and 22-keto-26-hydroxycholesterol in 
MeOD. 
22-keto-cholesterol. 1H NMR (600 MHz, CD3OD):  5.34 (m, 1H, H-6), 3.40 (m, 1H, H-3), 2.52-
2.62 (m, 2H, H-20, H-23), 2.45 (m, 1H, H-23), 2.23 (m, 1H, H-4), 1.95-2.07 (m, 2H, H-7, H-12), 
1.88 (dt, J = 13.0, 3.5 Hz, 1H, H-1), 1.78 (m, 1H, H-2), 1.45-1.67 (m, 8H, H-2, H-7, H-11, H-15, 
H-16, H-17, H-25), 1.41 (m, 1H, H-24), 1.31 (m, 1H, H-12), 1.19 (m, 1H, H-16), 1.10 (d, J = 7.0 
Hz, 3H, H-21), 1.04-1.09 (m, 2H, H-1, H-14), 1.03 (s, 3H, H-19), 0.98 (td, J = 11.0, 5.0 Hz, 1H, 
H-9), 0.90 (m, 6H, H-26, H-27), 0.76 (s, 3H, H-18); 13C NMR (150 MHz, CD3OD):  217.8 (C-
22), 141.9 (C-5), 122.1 (C-6), 72.1 (C-3), 57.3 (C-14), 53.6 (C-17), 51.4 (C-9), 50.2 (C-20), 43.4 
(C-13), 42.6 (C-4), 40.8 (C-12), 40.4 (C-23), 38.3 (C-1), 37.7 (C-10), 36.8 (C-8), 33.1 (C-24), 
32.7 (C-7), 31.8 (C-2), 28.6 (C-25), 28.2 (C-16), 25.8 (C-15), 22.5 (C-27), 22.0 (C-11), 19.6 (C-
19), 16.7 (C-21), 13.2 (C-26), 12.2 (C-18). 
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22-keto-26-hydroxycholesterol. 1H NMR (600 MHz, CD3OD):  5.34 (br d, J = 5.1 Hz, 1H, H-6), 
3.30-3.42 (m, 3H, H-3, H-26), 2.58-2.66 (m, 2H, H-20, H-23), 2.46 (ddd, J = 17.6, 9.2, 5.9 Hz, 
1H, H-23), 2.22 (m, 2H, H-4), 1.94-2.03 (m, 2H, H-7, H-12), 1.88 (dt, J = 13.6, 13.3 Hz, 1H, H-
1), 1.79 (m, 1H, H-2), 1.44-1.70 (m, 10H, H-2, H-7, H-8, H-11, H-15, H-16, H-17, H-24, H-25), 
1.30-1.34 (m, 2H, H-12, H-24), 1.21 (m, 1H, H-16), 1.15 (m, 1H, H-15), 1.11 (d, J = 7.0 Hz, 3H, 
H-21), 1.04-1.10 (m, 2H, H-1, H-14), 1.03 (s, 3H, H-19), 0.98 (td, J = 11.2, 5.0 Hz, 1H, H-9), 
0.91 (d, J = 6.6 Hz, 3H, H-27), 0.76 (s, 3H, H-18); 13C NMR (150 MHz, CD3OD):  217.0 (C-22), 
141.2 (C-5), 122.1 (C-6), 72.1 (C-3), 67.7 (C-27), 57.1 (C-14), 53.3 (C-17), 51.3 (C-9), 50.2 (C-
20), 43.2 (C-13), 42.7 (C-4), 40.6 (C-12), 40.1 (C-23), 38.3 (C-1), 37.4 (C-10), 35.9 (C-25), 32.7 
(C-7), 32.5 (C-8), 31.9 (C-2), 28.1 (C-16), 27.4 (C-24), 25.4 (C-15), 21.8 (C-11), 19.6 (C-19), 
16.7 (C-21), 16.6 (C-27), 12.0 (C-18). 
2.9.4 Supporting methods 
Method S1. Plant material and RNA extraction. 
Veratrum californicum plant material was obtained from wild populations in northern Utah. 
Tissue culture was initiated from wild collected seed and grown in the dark at 24°C on a 
combination of Linsmaier and Skoog vitamins (Linsmaier E.M. 1965) and Murashige and Skoog 
media(Murashige 1962) supplemented with 0.5 mg/l 1-naphthaleneacetic acid (Sigma). Refer to 
Table S9 for detailed media components. RNA extraction for each tissue (bulb, flower, leaf, fall 
rhizome, spring rhizome, fall root, green shoot, white shoot, and tissue culture samples) was 
performed as previously described (Johnson et al. 2012) (protocol 13). RNA quantity and 
integrity were evaluated with a NanoDrop 2000 (Thermo Scientific) and a Bioanalyzer 2100 
(Agilent Technologies) prior to cDNA library preparation. 
Method S2. Veratrum californicum metabolite extraction for quantitation by LC-MS/MS. 
Extracts were prepared by grinding frozen plant tissue in liquid nitrogen followed by 5 minutes of 
vortexing in 70% ethanol added in a 200 µl to 100 mg w/v ratio. Samples were subject to 
centrifugation for 10 minutes (14,000 X g) at room temperature and the supernatant filtered 
through a 0.2 µm PTFE membrane (Millipore) prior to injection. Extracts were diluted 10-10,000 
fold with 70% ethanol, depending on alkaloid concentration, prior to LC-MS/MS analysis (refer 
to LC-MS/MS protocol in Experimental Procedures). 
Method S3. Transcriptome assembly and determination of relative contig expression. 
cDNA library construction, Illumina paired-end sequencing, and de novo transcriptome 
assembly for Veratrum californicum were performed at the National Center for Genome 
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Resources (Santa Fe, New Mexico). For the transcriptome assembly, 50 bp paired-end Illumina 
reads for each tissue were first examined for gross abnormalities and poor sequence quality 
and trimmed with the FASTX Toolkit. (http://hannonlab.cshl.edu/fastx_toolkit). Quality control 
was as previously described (Kilgore et al. 2014).The reads were 5′ and 3′ quality trimmed using 
a Phred score of 15 to eliminate noisy reads. Subsequently, short contig assembly was 
performed using the de Bruijn graph-based assembler ABySS (Assembly by Short Sequences) 
several times with varying k-mer lengths to generate 20 sets of synthetic ESTs (Expressed 
Sequence Tags) with lengths between 100 – 500 base pairs (Birol et al. 2009, Simpson et al. 
2009). ABySS scaffolder was used to scaffold the synthetic ESTs and GapCloser from 
SOAPdenovo (Short Oligonucleotide Analysis Package) to close the NNN gap spacers (Li et al. 
2010). Lastly, the assembly was completed by combining the obtained scaffolds using MIRA 
(Mimicking Intelligent Read Assembly) in the EST assembly mode (Chevreux 2005). Post 
processing included translational predictions for each contig using ESTSCAN (Iseli et al. 1999, 
Lottaz et al. 2003), protein product motif annotation written to GFF3 files (General Feature 
Format), and determination of expression data by alignment analysis of the trimmed reads to 
the assembled contigs using BWA (Burrows-Wheeler Aligner) (Li and Durbin 2009). To further 
enable comparison of gene expression between various tissues, the number of reads aligned to 
each contig was normalized by dividing by the total number of reads from the respective tissue 
sample. Functional annotations to each predicted protein sequence were obtained using Pfam 
(Punta et al. 2012), Superfamily (Gough et al. 2001), and Uniprot (UniProt 2013).  
Method S4. Transcriptome dataset interrogation using Haystack and PlantTribes. 
Haystack (http://haystack.mocklerlab.org/) input parameters included a value of 20 for fall root, 
fall rhizome, spring rhizome and bulb and a value of 1 for leaf, flower, white shoot, green shoot, 
and tissue culture 1- and 2 weeks after transfer to new media. A correlation cutoff value of 0.7 
was used instead of the default of 0.8 to avoid missing true positives. 
Gene family circumscriptions in PlantTribes were calculated using the similarity-based clustering 
of gene models from Arabidopsis thaliana (v. 7), Carica papaya (v.1), Populus trichocarpa (v. 1), 
Medicago truncatula (v. 1), Oryza sativa (v. 5), Sorghum bicolor (v. 1), Selaginella moellendorffii 
(v. 1), Physcomitrella patens (v. 1), and Chlamydomonas reinhardtii (v. 1) genome annotations 
using TribeMCL (Enright et al. 2003, Enright et al. 2002). Translated transcript assemblies for 
Veratrum californicum, Narcissus sp. aff. pseudonarcissus (daffodil), and Colchicum autumnale 
(autumn crocus) were sorted into the resulting gene family clusters using BLAST followed by 
multiple sequence alignment and gene tree estimation. In addition to this MCL (Markov CLuster 
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algorithm) clustering approach, we developed a complete minimal representative dataset from 
all available plant species of cytochrome P450 genes relevant to alkaloid biosynthesis to identify 
candidate cytochromes P450. 
 
Multiple sequence alignment and phylogenetic tree estimation were done on these relevant 
tribes and gene families using the MAFFT (Multiple Alignment using Fast Fourier Transform) 
alignment software (Katoh et al. 2009) and RAxML (Randomized Axelerated Maximum 
Likelihood) for maximum likelihood tree generation (Stamatakis 2006). 
 
The RNA-seq transcriptome assembly sequences from C. autumnale and Narcissus were 
included in the tribe clustering steps (Supporting Data S1). These two species are also lillioid 
monocots but do not produce cyclopamine (but instead make the unrelated alkaloids colchicine 
and galanthamine, respectively), C. autumnale and Narcissus sequences were included in order 
to facilitate identification of tribe clusters that only contain Veratrum californicum genes, which 
were then assigned a higher priority for biochemical validation.  
 
Selection criteria were established to score and sort the resulting clades, positive criteria were 
given a +1 each while penalizations were scored as a -1 each. A given clade was scored on the 
percentage of clade members that significantly co-localized with cyclopamine (e.g. present in 
the Haystack output dataset). Clades that did not contain any genes that fit the Haystack model 
were penalized. Clades containing genes that were not significantly co-localized with the 
alkaloid were penalized. Lastly, clades that contain genes from species that do not produce 
cyclopamine incurred a score penalty and were not chosen for initial biochemical 
characterization. These criteria were combined to score and rank the clades that contain 
Haystack output gene members to identify the clade(s) with the highest likelihood of containing 
genes that function in the steroid alkaloid biosynthesis pathway. 
 
Method S5. Construction of viral expression vectors. 
Candidate contigs obtained from Haystack analysis were subjected to BLAST searches 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and global alignments to homologous, experimentally 
characterized gene sequences with the CLC Main Workbench 6.8, for prediction of the open 
reading frame. Where the reading frame appeared incomplete, Rapid Amplification of cDNA 
Ends (RACE) was used to obtain the complete coding sequence. Veratrum californicum cDNA 
was prepared from root RNA extracts using M-MLV Reverse Transcriptase (Invitrogen) 
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according to manufacturer’s instructions. All primer sequences and PCR programs can be found 
in Tables S11 and S12, respectively.  
The cDNAs encoding CYP90B27 (accession numbers KJ869252, KJ869253), CYP90G1 
(accession numbers KJ869258-KJ869261), GABAT1 (accession numbers KJ869262-
KJ869264) and γ-aminobutyrate transaminase 2 (GABAT2) (accession number KJ869265) were 
determined to be full length. CYP90B27 and CYP90G1 were amplified by Polymerase Chain 
Reaction (PCR) from cDNA with Phusion DNA polymerase (New England Biolabs) using 
primers 1-4 and 7-8, respectively, and initially ligated into the pCR-Blunt II-TOPO vector 
(Invitrogen). Two rounds of amplification were required for CYP90B27 by nested PCR. 
Subsequently, CYP90B27 was amplified from pCR-Blunt II-TOPO with primers 5 and 6 
introducing NotI/BamHI restriction sites into the PCR products at the 5’ and 3’ ends of the open 
reading frame. The amplified product and pVL1392 Baculovirus transfer vector (BD 
Biosciences) were digested with NotI/BamHI and ligated together using Rapid Ligase 
(Promega). Ligated constructs were transformed into E. coli DH5α competent cells. CYP90G1 
was amplified with primers 9 and 10, introducing PstI/XbaI restriction sites at the 5’ and 3’ end of 
the open reading frame. The amplified product, along with pVL1392, was digested with 
PstI/XbaI and subject to ligation and transformation. 
GABAT1 and GABAT2 were directly amplified from cDNA using primers 11, 12 incorporating 
BglII/EcoRI restriction sites at the 5’ and 3’ end of the open reading frame and 21, 22, 
incorporating PstI/XbaI restriction sites at the 5’ and 3’ end of the open reading frame, 
respectively. GABAT1 and pVL1392 were subject to restriction digest with BglII/EcoRI 
preceding ligation and transformation. GABAT2 was digested with XbaI/PstI, preceding ligation 
and transformation. 
RACE was required to determine the 5’ sequence of CYP94N1 gene (accession numbers 
KJ869254-KJ869257). RACE ready cDNA was prepared using the GeneRacer Kit (Invitrogen) 
according to manufacturer’s instructions using V. californicum root RNA. Primers 13 and 15 
were used for PCR (round 1), followed by amplification using primers 14 and 16 (round 2). 
Resulting RACE fragments were cloned into PCR-Blunt II-TOPO. The full-length gene was 
directly amplified from V. californicum root cDNA with primers 17 and 18, incorporating 
BglII/EcoRI restriction sites at the 5’ and 3’ end of the open reading frame. The amplified 
product was digested with Bglll/EcoRI and ligated into pVL1392 digested with the same 
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enzymes. Each characterized V. californicum contig and subsequent enzyme designation can 
be found in Table S6. 
The cDNA encoding GABA transaminase isozyme 2 from Solanum lycopersicum (tomato 
GABAT2) implicated in steroid alkaloid biosynthesis (accession number AY240230) was 
isolated from S. lycopersicum using the Qiagen RNA-easy kit for RNA extraction followed by 
cDNA synthesis as described above. Tomato GABAT2 was amplified by PCR using Primers 19 
and 20, incorporating PstI/XbaI sites at the 5’ and 3’ end of the open reading frame. The 
amplified product and pVL1392 were subject to restriction digest with PstI/XbaI and ligated 
together, preceding transformation. 
Method S6. Virus co-transfection, amplification, and protein production. 
Each pVL1392 expression construct was independently co-transfected with the Baculogold 
Linearized Baculovirus (BD Biosciences) into S. frugiperda Sf9 cells according to 
manufacturer’s instructions. Sf9 cells were maintained as previously described (Gesell et al. 
2011). Virus amplification and protein production proceeded as previously described (Gesell et 
al. 2009). Each cytochrome P450 virus construct was co-expressed with virus containing E. 
californica cytochrome P450 reductase (CPR) while the GABAT1 was produced by single 
infection. Sf9 cell cultures were also infected with several constructs in parallel. Combinations of 
each virus used in multiple infections can be found in Table S13. Equal volumes for each virus 
were used in the multiple infections and adjusted to a total viral volume of 2.5 ml. 
Method S7. Extraction of multiple infections for Sf9 in vivo product production.  
Baculovirus infections were carried out for production of each enzymatic product in S. frugiperda 
Sf9 cells and collected as stated in Method S6. 1 ml each of Sf9 cells expressing the various 
combinations of virus were extracted with 2 volumes of ethyl acetate by vortexing (1 min), 
centrifugation (16,000 x g; 2 min), and were taken to dryness under N2. Samples were either 
derivatized with 40 µl of Sylon HTP and injected onto the GC-MS using the protocol stated in 
Experimental Procedures or were re-suspended in 50 µl of 80% methanol and analyzed by 
LC/MS-MS according to the protocol in Experimental Procedures. 
Method S8. Assays to clarify order of enzymatic transformations. 
Assay for GC-MS: Cytochrome P450 enzyme assay conditions were identical to those stated 
above using S. frugiperda Sf9 cell suspensions with the following modifications. First, 12 assays 
each containing CYP90G1 + CPR, CYP94N1 + CPR, or control cytochrome P450 + CPR and 
each with pure 22(R)-hydroxycholesterol were allowed to incubate overnight at 30°C. Like 
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assays were pooled, extracted 3 times with 2 volumes ethyl acetate, dried under N2, and re-
suspended in 180 µl of 25% DMSO. Extracts containing the enzymatic product of the 22-
hydroxycholesterol 26-hydroxylase/ oxidase + CPR and 22(R)-hydroxycholesterol were divided 
equally and used as substrate for 6 assays containing CYP90G1 + CPR and 6 assays 
containing control cytochrome P450 + CPR. Extracts containing the enzymatic product of 
CYP90G1 + CPR and 22(R)-hydroxycholesterol were divided and used as substrate in 6 assays 
containing 22-hydroxycholesterol 26-hydroxylase/ oxidase + CPR and 6 assays containing 
control cytochrome P450 + CPR. Control P450 + CPR assay was run in parallel, treated 
identically and added to another control P450 assay. Assays were allowed to incubate for 20 
min at 30°C then stopped by addition of 20 µl of 20% TCA with vortexing. Like assays were 
pooled, extracted, derivatized, and analyzed by GC-MS using the protocol stated in 
Experimental Procedures. Refer to Figure S11 a for an overview of the experiment.  
Assay for LC-MS/MS: All assays used crude Sf9 cell suspensions. Enzyme assays started with 
a combination of CYP90B27 + CPR and CYP94N1 + CPR (8 individual reactions) in parallel to 
CYP90B27 + CPR and CYP90G1 + CPR (8 reactions). Assays were extracted, and added to 
CYP94N1 + CPR, CYP90G1 + CPR, or GABAT1 for several possible enzyme combinations (4 
reactions each). Like samples were pooled, extracted, and added to 2 reactions each with 
enzyme not yet utilized previously. Refer to Figure S11 b for an overview of the experiment. 
Samples were taken at each step post extraction for LC-MS/MS analysis and run by the 
protocol stated in Experimental Procedures.  
 
Method S9. Enzymatic product purification for NMR and high resolution MS for structure 
elucidation. 
Large-scale 750 ml S. frugiperda Sf9 cultures were grown expressing viral combinations 5-7 
(Table S13) of the Veratrum californicum enzymes as previously described (Gesell et al. 2009). 
Cells were collected after three days and re-suspended in 10 ml of 100 mM tricine pH 7.4/ 5 mM 
thioglycolic acid; then extracted 3 times with 2 volumes of hexane or ethyl acetate. The 
remaining aqueous supernatant was extracted once with 1 volume of hexane or ethyl acetate. 
Extracts for each infection were then pooled, dried under N2, and re-suspended in 5 ml of 
absolute methanol.  
The extracts were purified on a Waters HPLC system equipped with a 2707 autosampler, 1525 
binary pump, 2998 photodiode array detector, and Waters Fraction Collector III. In some cases, 
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samples were cleaned up by Solid Phase Extraction (SPE), before HPLC purification. For 
HPLC, extracts were concentrated to 500 µl and then injected in 50 µl portions onto a 
Phenomenex Gemini C-18 NX column (150 X 2.00 mm, 5 µm) with the same solvents used for 
LC-MS/MS as described in Experimental Procedures with the following binary gradient: Solvent 
B was held at 20% for 2 min, then 2-11 min 20-30% B, 11-18 min 30-100% B, 18-30 min 100% 
B, 30-31 min 100-20% B, and held at 20% B for an additional 5 minutes. The flow rate was 0.5 
ml/min; 0.5 ml fractions were collected. The resulting fractions were then analyzed by GC-MS or 
LC-MS/MS as described in Experimental Procedures, and selected samples were analyzed by 
NMR or by high resolution MS. NMR spectra were acquired in MeOD at 600 MHz on a 
BrukerAvance 600 MHz spectrometer equipped with a BrukerBioSpin TCI 1.7 mm 
MicroCryoProbe. Proton, gCOSY, ROESY, gHSQC, and gHMBC spectra were acquired; 13C 
chemical shifts were obtained from the HSQC and HMBC spectra. Chemical shifts are reported 
with respect to the residual non-deuterated MeOD signal. Refer to Data S2 for NMR 
designations for 22-keto-cholesterol and 22-keto-26-hydroxycholesterol. For high resolution MS, 
samples were diluted 1:10 in 80% acetonitrile:water (LC-MS grade) containing 0.1% formic acid 
and infused into an LTQ-Orbitrap Velos Pro (Thermo-Fisher Scientific, San Jose, CA) using a 
Triversa Nanomate (Advion, Ithaca, NY). Data were collected in positive ion mode, detected in 
the Orbitrap at a nominal resolution setting of 60,000 at m/z 400. Precursors were determined 
with a wide SIM scan (m/z 385-430). Precursors were isolated in the ion-trap and transferred to 
the HCD cell for fragmentation at 35 NCE (m/z 418) and 50 NCE (m/z 398). Data were analyzed 
manually using the Qualbrowser application of Xcalibur (Thermo-Fisher Scientific, San Jose, 
CA). 
Method S10. Phylogenetic analysis of cytochrome P450 enzymes across species using 
deep transcriptome sequence data from 1KP and MonAToL projects. 
Sequences for P450 genes were identified and pulled from various sources. Transcriptome data 
for monocotyledon taxa were taken from the MonAToL project (DEB-0830020) and the 1KP 
project (https://sites.google.com/a/ualberta.ca/onekp/home). Taxa were selected to represent 
major clades but were not exhaustive of the sampling available. We also included genome 
sequences from the 22 sequenced land plant genomes used by the Amborella genome project 
to represent eudicots and other angiosperms (Amborella Genome 2013). The final taxa used in 
reconstructing the P450 gene tree can be found in Table S8. Additionally, a P450 sequence 
from S. cerevisiae was used as the outgroup (GenBank Accession: U34636.1).  
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Transcriptomic data was assembled using Trinity r2013-02-25 and resulting assemblies were 
filtered using FPKM (fragments per kilobase of exon per million fragments mapped). Sequences 
where an isoform represented less than 1% of all reads mapping to a gene were discarded. 
Assemblies were translated using the ORF estimation Transdecoder r20131110 software 
packaged with Trinity. Blastp (Camacho et al. 2009) was used to blast genomic and 
transcriptomic amino acid sequences using the S. lycopersicum GAME4, GAME6, GAME7, and 
GAME8 (Refer to Table S7 for accession numbers) and Veratrum californicum CYP90B27, 
CYP90G1, and CYP94N1 (Refer to Table S7 for accession numbers) P450 amino acid 
sequence. Best blast hits were identified using an initial e-value threshold of 1e-10 followed by a 
minimum overlapping length of 85% between the query and subject sequences. These filtering 
criteria resulted in putative P450 genes of at least 1017 basepairs in length for all taxa.  
Amino acid sequences for all putative P450 sequences were aligned using MAFFT v.7.029b 
(Katoh and Standley 2014) under default settings. Trees were estimated using RAxML v.8.0.22 
(Stamatakis 2006) under the GTR + Γ evolutionary model with 500 bootstrap replicates and S. 
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Chapter 3: Production of Veratrum californicum secondary 
metabolites in Camelina sativa seed 
3.1 Summary 
Economically feasible systems suitable for heterologous production of secondary metabolites 
originating from complex species are in demand. Established systems such as Escherichia coli 
and Saccharomyces cerevisiae are not always suitable for expression of plant and animals 
genes due to several differences including mechanisms of post-translational modifications and 
cellular organization. An emerging oilseed crop, Camelina sativa, has recently been engineered 
to produce novel oil profiles, jet fuel precursors, and small molecules of industrial interest. One 
medicinally relevant secondary metabolite, cyclopamine, is currently used to produce medicines 
in clinical trials, and the future supply of this potential cancer treatment is uncertain. The sole 
source of cyclopamine, Veratrum californicum, is slow growing and not amendable to cultivation. 
In order to establish C. sativa as a system for the production of medicinally relevant compounds, 
we introduced four genes from V. californicum involved in steroid alkaloid biosynthesis. These 
four genes produce verazine, the hypothesized precursor to cyclopamine. Herein, we 
successfully engineered C. sativa to produce verazine, as well as other V. californicum 
secondary metabolites, in seed. 
3.2 Significance statement 
Verazine was produced in Camelina sativa seeds by heterologous expression of Veratrum 
californicum genes CYP90B27, CYP94N1, CYP90G1, GABAT1 and the Arabidopsis thaliana 
gene GAD2. This is the first report of verazine production in a heterologous system. In addition, 
this is the first report of C. sativa use for the production of medicinally relevant compounds. 
3.3 Author contributions 
I, (Megan M. Augustin) in addition to Ashutosh K. Shukla and Cynthia Holland constructed 
vectors for transformation. I performed all plant transformations and seed collection. I, with the 
help of Linna Han, extracted seeds for metabolite analysis. I ran all samples on the LC-MS/MS 
and analyzed the results. I generated all data for all figures. I produced all figures and wrote the 
manuscript. 
3.4 Introduction  
Industrial production of plant derived natural products for medicinal use can be unachievable by 
either traditional chemical synthesis or agricultural techniques. Chemical synthesis techniques 
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often require harsh conditions and result in toxic byproducts. The complex stereochemistry of 
many natural products can also complicate synthesis. In addition, direct extraction of medicinal 
compounds from source plant species is not always a viable alternative, as many produce low 
natural yields and/or not amendable to cultivation (Atanasov et al. 2015). The development of a 
low input heterologous eukaryotic system is in demand for high value medicinal compounds. 
One potential production system is the emerging agricultural oilseed crop Camelina sativa.  
C. sativa is an attractive alternative to current heterologous production systems for plant natural 
products such as Escherichia coli and Saccharomyces cerevisiae because of its molecular 
compatibility with other plant species, as well as its low input requirements. The close 
phylogenetic relatedness to the well-studied model organism Arabidopsis thaliana, in addition to 
ease of transformation and a sequenced genome, offers a foundation of genetic and molecular 
tools that can be utilized for metabolic manipulation (Kagale et al. 2014, Lu and Kang 2008). 
Complication arising from codon usage and post-translational modifications would be minimal in 
a plant production system as opposed to the distantly related microbial alternatives. Advantages 
to cultivation of C. sativa include low water- and nutrient input, as well as its compatibility with 
current agricultural practices (Putnam et al. 1993). In addition, its short growing season (ca. 100 
days) along with cold tolerance has shown its potential for growth and harvest prior to the 
normal growing season, therefore maximizing land use without effecting normal crop production 
(Putnam et al. 1993). 
C. sativa is under extensive investigation for its use in biofuel, industrial oil/lubricants, and high 
value metabolite production. Genetic manipulation of fatty acid content by heterologous 
expression of novel Cuphea FatB genes has altered fatty acid content in C. sativa by increasing 
medium chain fatty acids, therefore mimicking the hydrocarbons present in Jet A fuel (Kim et al. 
2015). Transgenic C. sativa was also shown to accumulate valuable liquid wax esters by 
addition of wax ester synthase from Mus musculus or Simmondsia chinensis and fatty acyl-CoA 
reductase from Mus musculus or Marinobacter aquaeolei (Iven et al. 2015). RNAi suppression 
of C. sativa type 1 diacylglycerol acyltransferase led to accumulation of 3-acetyl-1,2-diacyl-sn-
glycerols, triacylglycerols with attractive chemical properties including reduced freezing point 
and viscosity (Liu et al. 2015). C. sativa has also been under investigation for the use in 
aquafeeds as a replacement for vegetable oils that lack omega-3 long chain polyunsaturated 
fatty acids (ω3 LC-PUFA). Accumulation of the highly desired ω3 LC-PUFA eicosapentaenoic 
acid and docosahexaenoic acid has also been achieved by heterologous expression of yeast, 
algae, and additional species’ genes involved in the delta6-desaturase pathway (Petrie et al. 
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2014, Ruiz-Lopez et al. 2014). These high yielding ω3 LC-PUFA lines of C. sativa have been 
shown to successfully replace fish oil in aquaculture (Betancor et al. 2015a, Betancor et al. 
2015b). Non-genetically modified C. sativa has also shown promise in aquaculture (Hixson et al. 
2013, Hixson et al. 2014a, Hixson et al. 2014b).  
In addition to advances in oil composition, genetically manipulated C. sativa has shown promise 
for the accumulation and storage of other highly valuable compounds. The production of the 
mono- and sesquiterpenes limonene and cadinene (respectively), in transgenic C. sativa could 
provide a robust and renewable source for these industrially useful terpenes, in addition to their 
potential use in jet fuel (Augustin et al. 2015a). C. sativa was also engineered to produce the 
biodegradable polymer poly-3-hydroxybutyrate (PHB). PHB can be used as a renewable 
component in bio-plastics, among other industrial uses (Malik et al. 2015). Moreover, production 
of these metabolites in seeds lends to easy harvest and long term storage, desirable traits for 
large scale production. We hypothesize, based on the previous success of metabolic 
engineering of C. sativa, that we can use C. sativa as a production system to produce 
medicinally useful small metabolites in seed. 
The stereochemically complex steroidal alkaloid cyclopamine is one medicinal compound 
currently under clinical investigation whose supply is predicted to fall short of potential demands 
upon FDA approval (Heretsch et al. 2010). Cyclopamine is best known for its teratogenic effects 
in lambs born to pregnant ewes that ingested the source plant Veratrum californicum (Keeler 
and Binns 1968). Cyclopamine’s mode of action is inhibition of the hedgehog pathway, mainly 
active during embryonic development, by direct binding to the transmembrane receptor 
Smoothend (Chen et al. 2002). Cyclopamine, and its semi-synthetic analog IPI-926, has shown 
promise in cancer therapy where mutations in the hedgehog pathway cause over activation 
leading to tumor growth, including pancreatic cancer, medulloblastoma, basal cell carcinoma, 
leukemia, colon cancer, and small cell lung cancer (Bahra et al. 2012, Batsaikhan et al. 2014, 
Berman et al. 2002, Jimeno et al. 2013, Lin et al. 2010, Olive et al. 2009, Taipale et al. 2000, 
Tremblay et al. 2009, Watkins et al. 2003). Cultivation of V. californicum for production of 
cyclopamine has yet to be successful, and cell cultures grow slowly and fail to produce 
substantial amount of cyclopamine (Song et al. 2014). Four genes have been discovered in the 
hypothesized biosynthetic pathway to cyclopamine (Augustin et al. 2015b). Together, the 
enzymatic products of these genes convert cholesterol to the predicted cyclopamine steroidal 
alkaloid precursor verazine. By transforming these four genes in addition to Arabidopsis 
glutamate decarboxylase 2 (GAD2), an enzyme required to produce the co-substrate γ-
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aminobutyric acid (GABA) in seed, we have successfully engineered C. sativa to accumulate 
verazine in seed (Turano and Fang 1998). 
3.5 Results 
3.5.1 Vector construction, plant transformation, and confirmation of construct integration 
Vector construction for plant transformation consisted of two parts. The first gene was cloned 
into an initial vector that contained a seed specific promoter and terminator. Next, the 
expression cassette (consisting of the 
promoter, gene, and terminator) was cut 
out by restriction enzyme digest and 
ligated into the multiple cloning site 
(MCS) of the plant expression vector 
pRSe3. Multiple expression cassettes 
were then cloned into the MSC of one 
plant transformation vector which 
allowed several genes to be transformed 
at once. Two plant expression vectors 
were constructed. One contained three 
genes involved in V. californicum steroid 
alkaloid biosynthesis and was 
designated CTOG (C= Cholesterol 22-
hydroxylase (CYP90B27), T= 22-
Hydroxycholesterol-26-al Transaminase 
(GABAT1), O= 22-Hydroxycholesterol 
26-hydroxylase/Oxidase (CYP94N1, and 
G= Glutamate decarboxylase 2 
(GAD2)). The second construct 
contained four genes involved in V. 
californicum steroid alkaloid 
biosynthesis and was designated 
CXTOG (X = 22-Hydroxy-26-aminocholesterol 22-oXidase (CYP90G1)). GAD2 was included in 
both vector constructs in order to increase the concentration of GABA in seed, a co-substrate 
required by GABAT1. The vector pRSe3 is a modified Ti (tumor inducing) plasmid from 
Agrobacterium that allows for genomic integration of the DNA contained between the left and 
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right border sequences (referred to as T-DNA), but does not allow for bacterial infection. The 
vector also contains a Kanamycin resistance gene for selection in bacteria and the DsRed gene 
for selection in C. sativa seed. C. sativa plants were transformed as previously described (Lu 
and Kang 2008). Initial confirmation of T-DNA integration into transformed C. sativa was 
achieved by visualization of DsRed by illuminating seeds with a green LED light and observing 
fluorescence through a red filter. After transgenic seeds were grown to the next generation, 
PCR analysis on selected CXTOG transgenic C. sativa confirmed integration of the construct 
(Figure 1 A). Gene expression was also confirmed by PCR analysis on cDNA derived from total 
developing seed RNA (Figure 1 B). In addition, production of metabolites as described below 
supported integration and expression of the transgenes. 
3.5.2 4000 QTRAP analysis for detection of V. californicum metabolites in transgenic C. 
sativa seeds 
Initial metabolite screening was performed on wild type and transgenic CTOG and CXTOG C. 
sativa seed extracts using LC-MS/MS with a 4000 QTRAP for detection of verazine and 
previously identified metabolites produced by the transgenes (Augustin et al. 2015b). 
Accumulation of 22-hydroxy-26-aminocholesterol, in addition to three unknown compounds with 
the same mass and similar fragmentation pattern, was detected in transgenic CTOG plants 
containing CYP90B27, CYP94N1, GABAT1, and GAD2, but lacking CYP90G1 (Figure 2). 22-
Keto-26-hydroxycholesterol and verazine were not detected. In CXTOG plants containing 
CYP90B27, CYP94N1, CYP90G1, GABAT1, and GAD2, 22-hydroxy-26-aminocholesterol was 
not detected, but 22-keto-26-hydroxycholesterol was found to accumulate. In addition to this 
compound, another peak eluted 1 minute later and appeared to have the same mass and 
similar fragmentation pattern (Figure 3). A peak for verazine was detected by a more sensitive 
scan (MRM scan) and appeared slightly above background and was not detected in the wild 
type plants, but further analysis and verification was desired (Figure 4). In addition, a novel peak 
eluted after verazine with the same fragment ion and was also not detected in the wild type or 
Sf9 extracts. 












3.5.3 Q-Exactive analysis for 
verazine detection 
In order to verify the 
accumulation of verazine in 
CXTOG transgenic C. sativa 
seeds, samples were analyzed 
by high-resolution mass 
spectrometry. The increased 
sensitivity of the Q-Exactive 
enhanced detection of verazine 
and allowed us to obtain 
accurate mass in addition to a 
mass spectrum (Figure 5). The 
detection of a peak with mass 
398.3418 in the transgenic C. 
sativa CXTOG extracts 
coincided with verazine 
produced in Sf9 cells. Both had 
only 0.25 ppm and 0.5 ppm mass measurement error, respectively, when compared to the 
calculated accurate mass of 398.3417. In addition, the defining fragment peak 126.1279 was 
found in the transgenic plant samples as well as the verazine from Sf9 cells. This mass 
corresponds to only 1.5 ppm mass measurement error when compared to the calculated 
accurate mass of 126.1277. All mass measurement errors fall far below the 5 ppm limit for 
determining compound identity. In addition to verazine, another metabolite with the same mass 
and similar fragmentation pattern was also detected in the transgenic C. sativa extracts (Figure 
5 F). 









C. sativa engineered to express CYP90B27, CYP94N1, CYP90G1, GABAT1, and GAD2 was 
shown to accumulate verazine, the hypothesized intermediate to the antineoplastic 
cyclopamine. In addition to verazine, 22-keto-26-hydroxycholesterol was also detected. 
Additional peaks with the same masses and similar fragmentation patterns occurred at different 
retention times in planta for both of these compounds, suggesting the possibility of alternative 
stereochemical isomers produced in C. sativa. Reduction/elimination of these side products may 
be achieved by introducing sequential cyclopamine biosynthetic enzymes once they are 
discovered. As described for A. thaliana engineered with three genes to produce dhurrin, a 
cyanogenic glucoside from Sorghum, many unintended side products accumulated in transgenic 
plants containing only two genes. When the third gene was introduced, and the pathway thereby 
complete, the unintended side products were no longer detected and the end product was 
greatly enhanced (Kristensen et al. 2005).  
Despite the absence of true verazine quantitation (due to a lack of available standard), it was 
observed that the production was quite low. Several possibilities exist for further engineering of 
C. sativa for increased verazine and sequential metabolite production in the future. As 
mentioned earlier, additional pathway enzymes may increase yield and drive the production of 
metabolites with the correct stereochemistry. Another possibility would be to increase the 
production of cholesterol in C. sativa, a precursor molecule for steroid alkaloids. Cholesterol has 
been found as only a minor steroid in C. sativa, so this may be limiting for metabolite production 
(Mansour et al. 2014). Overexpression of oxidosqualene cyclases such as cycloartenol 
synthase or lanosterol synthase may increase the available cholesterol (Ohyama et al. 2009). In 
addition, upregulation of bottleneck enzymes in the mevalonic acid pathway may enhance yield. 
As previously demonstrated by Augustin et al.2015aq, overexpression of the rate limiting 
enzyme 1-deoxy-d-xylulose-5-phosphate synthase (DXS) in C. sativa engineered to produce 
limonene and cadinene significantly increased terpene production. A deeper understanding of 
cholesterol biosynthesis in plants will enhance decisions in this regard. Engineering of this 
pathway into another system such as S. cerevisiae is also a viable option, but would not include 
the benefits of a C. sativa production system as described earlier. 
Cultivation of C. sativa as an agricultural crop is industrially and environmentally attractive due 
to its low input requirements and chemical properties. Efficient use of cultivatable land by 
growing C. sativa prior to the typical growing season will provide an opportunity for metabolite 
and fuel production without jeopardizing food crops or compromising undeveloped wilderness 
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(Bansal and Durrett 2015). In addition, after metabolite extraction, the leftover material can be 
utilized as biofuels or other industrial applications, wasting little material (Asomaning et al. 
2014). Herein, we demonstrated the production of V. californicum secondary metabolites in C. 
sativa, highlighting the possibilities for future engineering and industrial production.  
3.7 Experimental procedures 
Cloning and plant transformation 
CYP90B27, CYP94N1, CYP90G1, and γ-aminobutyrate transaminase 1 (GABAT1) were cloned 
from Veratrum californicum total root cDNA and glutamate decarboxylase 2 (GAD2) was cloned 
from Arabidopsis thaliana (L.) Heyn., ecotype Columbia (Col-0) total leaf cDNA. V. californicum 
plant tissues were obtained from wild collection in Northern Utah, USA and the Arabidopsis 
tissue was obtained onsite (Donald Danforth Plant Science Center Greenhouse, St. Louis, MO, 
USA). Total RNA from V. californicum was extracted as previously described (Johnson et al. 
2012). Arabidopsis RNA was extracted using an RNeasy Plant Mini Kit (Qiagen). cDNA 
synthesis followed using MMLV-RT. Genes were first ligated into cassette vectors to provide 
each with a seed specific promoter and terminator before transfer into the plant expression 
vector pRSe3, a binary vector with kanamycin and DsRed selection markers. pRSe3 is based 
on pRSe2, with an enhanced multiple cloning site (Augustin et al. 2015a). The following genes 
were ligated into each cassette vector providing the following seed specific 
promoters/terminators: CYP90B27 (Oleosin/Oleosin); CYP94N1 (Napin/Glycinin); GABAT1 
(Napin/Glycinin); CYP90G1 (Napin/Glycinin); and GAD2 (Glycinin/Glycinin). Final constructs 
were made both with (CXTOG) and without (CTOG) CYP90G1. Plants were transformed as 
previously described (Lu and Kang 2008). Transgenic seeds were screened as previously 
described (Augustin et al. 2015a). Verazine, 22-keto-26-hydroxycholesterol, and 22-hydroxy-26-
aminocholesterol were heterologously produced in Sf9 insect cells as previously described 
(Augustin et al. 2015b). 
DNA extraction, RNA extraction, and PCR  
DNA was extracted from leaf tissue of selected plants grown from seeds exhibiting red 
fluorescence for verification of construct integration using the DNeasy Plant Mini Kit (Qiagen). 
PCR was performed with primers GAD2_F_NdeI 
(CACACATATGGTTTTGACAAAAACCGCAACGA), and GAD2_RC_NotI 
(CACAGCGGCCGCTTAGCACACACCATTCATCTTCTT) and the following temperature 
program parameters: 2 min 95 °C, 1 cycle; 30 s 95 °C, 30 s 52 °C, 1 min 72 °C, 30 cycles; final 
Augustin, Megan, 2015, UMSL, p.98 
 
 
extension at 72 °C for 5 min. RNA was extracted from developing seeds with the RNeasy Plant 
Mini Kit (Qiagen). cDNA synthesis followed using the RNA to cDNA EcoDry kit (Clontech) and 
expression was confirmed by amplification of the GAD2 gene using the same primers and PCR 
cycle described above. Amplification of tubulin was included as a control. 
Seed extraction 
T2 (CTOG) and T3 (CXTOG) generation seeds were extracted based upon the protocol in the 
acyl-lipid metabolism chapter in The Arabidopsis Book (Li-Beisson et al. 2013). Hot isopropanol 
(1.5 ml, 75°C) was added to 15-20 mg of seeds and incubated for 15 min. Seeds were then 
crushed with a glass rod followed by the addition of chloroform and H2O (0.75 ml and 0.3 ml, 
respectively). Next, samples were sonicated in a sonication bath for 10 min followed by robust 
shaking for 1 hour at room temperature (RT). Tubes were then vortexed for 10 seconds and 
centrifuged (1,500 x g, 2 min, RT). The liquid was moved to a fresh tube and the remaining 
tissue was re-extracted once with 2 ml of chloroform:methanol (2:1) and once with 1 ml of 
chloroform:methanol (2:1). Supernatants were combined prior to addition of 0.5 ml 1 M KCl. 
Samples were vortexed, centrifuged, and the aqueous upper phase was removed. This 
extraction was repeated once by the addition of 1 ml H2O. The organic phase was dried to 
completion under N2. Extracts were re-suspended in 80% methanol and filtered with a 0.2 µ 
PTFE filter (Millipore) before LC-MS/MS analysis. 
LC-MS/MS analysis 
Seed extracts were first analyzed by LC-MS/MS using a 4000 QTRAP (ABSciex) as previously 
described (Augustin et al. 2015b). Selected seed extracts were additionally analyzed by high-
resolution mass spectrometry using a Q-Exactive (Thermo Fisher) coupled to an Agilent1200 
microLC system. Samples were separated by a PLRP-S column (100 x 0.5 mm, 100Å, 3µ; 
Higgins Analytical) with a flow rate of 15 µl/min and the following solvent/gradient system: 
solvent A (0.05% formic acid/0.01% ammonium hydroxide v/v in H2O; solvent B (0.05% formic 
acid/0.01% ammonium hydroxide v/v in 90% acetonitrile]: Solvent B was held at 10% for 4 min, 
then 4-10 min 10-40% B, 10-18 min 40-45% B, 18-20 min 45-100% B, 20-21 min 100% B, 21-
22 100-10% B and held at 10% B for an additional 10 minutes. Results were analyzed using 
Analyst 1.5 (Applied Biosystems) for data generated with the 4000 QTRAP and Xcalibur 3.0.36 
(Thermo Scientific) for data generated by Q-Exactive. 
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Chapter 4: Concluding remarks and future perspectives 
With the conclusion of this work, four genes have been discovered in the biosynthesis of steroid 
alkaloids in V. californicum. The enzymes encoded by these genes synthesize verazine from 
cholesterol, a hypothesized intermediate of the antineoplastic cyclopamine. Verazine itself could 
serve as a precursor molecule for the semi-synthesis of a variety of steroid alkaloids. The 
enzymatic introduction of nitrogen can reduce the number of steps required to produce other 
potentially useful steroid alkaloids that would otherwise require harsh chemical reactions 
(Atanasov et al. 2015). Also of note, verazine has been shown to be a significant anti-fungal 
agent, which could be useful for the development of novel anti-fungal treatments (Kusano et al. 
1987).  
The biosynthetic pathway to verazine, at least in this heterologous system, was clarified. The 
pathway found herein is slightly different than what was predicted previously. The V. 
californicum metabolite 22-keto-26-hydroxycholesterol does not appear to play a role in the 
formation of verazine. It was also clarified that the C-22 position was hydroxylated first, followed 
by hydroxylation at position C-26. We also established the nitrogen source for GABAT1 as 
GABA, not arginine. In addition, oxidation at position C-22 must occur after nitrogen 
incorporation, thus driving the formation of the piperidine ring. We also found that gene 
expression does not entirely overlap with the accumulation of cyclopamine. These enzymes 
may be involved in the formation of additional steroid alkaloids in V. californicum, as the plant 
makes several types which may all rely on these initial biosynthetic genes. These discoveries, 
however, are only the beginning for future cyclopamine production. 
Continued research is necessary for complete elucidation of this pathway. As the semi-synthetic 
analog IPI-926 proceeds in clinical trials, and the prospects of cyclopamine and its derivatives 
remain high for cancer treatment, the demand for this compound will outweigh the supply. 
Several more complex steps are required to form cyclopamine from verazine including 
hydroxylation at position C-16 followed by closure of the E-ring. Hydroxylation at position C-12 
must follow, preceding the notable ring rearrangement for formation of the C-nor-D-homo 
skeleton. Opening and closing of the E-ring must occur with the addition of an oxygen atom 
before cyclopamine can be formed as well. Once these genes have been discovered, future 
work on cyclopamine production at an industrial level can be continued. The synthesis of IPI-
926, however, could possibly initiate from one of the cyclopamine precursors, and full pathway 
elucidation may not be required. 
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In addition, it has been demonstrated that the V. californicum genes CYP90B27, CYP94N1, 
CYP90G1, and GABAT1 are functional in the heterologous expression system C. sativa. 
Accumulation of verazine was confirmed in transgenic seed. Continued efforts are necessary to 
increase production and overcome bottlenecks, but the basis for production has been 
established. Moreover, the use of C. sativa as a heterologous production system for medicinally 
useful metabolites has been explored and is supported by the work herein. Future work on C. 
sativa, in conjunction with the vast knowledge base from the close relative A. thaliana, can help 
achieve greater accumulation of metabolites by manipulation of primary metabolic pathways. 
New technologies, such as RNAi, can help downregulate specific genes without eliminating 
them completely, allowing for the fine tuning of metabolic pathways for optimal metabolite 
production. C. sativa will, however, remain in the infancy stage as a production system unless 
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